Welcome

STRATEGIC PLAN &
RACIAL EQUITY ACTION PLAN

Fenway @ 50

Response to COVID-19

Healthcare

Education

Research

Public Health

Advocacy

Events

Supporters

Boomerangs

Your Care, Your Community

Fenway Health advocates for and delivers innovative, equitable, accessible health care, supportive services, and transformative research and education. We center LGBTQIA+ people, BIPOC individuals, and other underserved communities to enable our local, national, and global neighbors to flourish.. Learn more by clicking on the sections above.

Message from our CEO

To Our Community Members,

Over the past year, Fenway Health marked its 50th anniversary in two ways that we expect will be remembered and remarked upon 50 years from now.

First, we applied five decades’ worth of knowledge and expertise gained in the provision of healthcare, study of science, and advocacy for health equity to the global fight against COVID-19:

Our scientists and researchers ran a Phase 3 clinical trial of the Astra Zeneca COVID-19 vaccine and participated in the CoVPN 3502 COVID-19 antibody study to learn more about how antibodies can be used to potentially stop the spread of COVID-19. We partnered with other community-based organizations to ensure that participants in our research studies were racially diverse and representative of the communities we serve.
We launched a free COVID-19 testing site in Boston for our patients and a second one in Everett, open by appointment to anyone. We partnered with the state’s Community Tracing Collaborative on COVID-19 infection contact tracing, and our team brought multilingual Spanish, Vietnamese, and Portuguese capacity as well as experience working with LGBTQIA+ communities to that effort.
Our policy experts advocated for sexual orientation and gender identity data collection in COVID-19 testing and vaccination at the local, state, and federal level, and gained support from the Massachusetts state legislature’s Health Equity Task Force.

Second, we laid the foundation for success over our next 50 years by approving an ambitious strategic plan that centers racial equity and social justice in Fenway’s operations, care, and services; advances health equity among those Fenway serves; and pushes to dismantle and redesign systems that deprive BIPOC and other underserved people of the opportunity to be healthy and thrive.

We have set ourselves on a path to achieving these goals by hiring a new Chief Operating Officer, Executive Vice President of Racial Equity and Social Justice, Vice President of Communications, and Vice President of Resource Development and Donor Engagement who bring a wealth of professional acumen and lived experience to our executive management team.
We joined a broad coalition of health care providers, LGBTQIA+ advocacy groups, and patients as a plaintiff in an historic lawsuit challenging a decision by the U.S. Department of Health and Human Services to eliminate the broad protections against discrimination in healthcare that were put in place by the Affordable Care Act. Those protections had prohibited discrimination against LGBTQIA+ people; people who seek or have obtained reproductive health care, including abortion and other pregnancy-related treatment; patients with limited-English proficiency, immigrants; and people living with HIV and other chronic illnesses. We were compelled and proud to take a stand on behalf of some of the most marginalized and at-risk members of our community, advancing a core principle at the heart of our mission – that all people deserve access to care, and that LGBTQIA+ people are entitled to the same rights as all others in our society.

Through it all, our staff has continued to meet the needs of the people who count on us, and to deliver on our mission. By expanding our telehealth program to ensure continuity of care during the COVID-19 public health emergency, we were able to care for more than 34,000 patients in 38 states, and earned recognition from the U.S. Health Resources & Service Administration for being one of just 36 community health centers in the country that exceed national clinical quality benchmarks for chronic disease management and preventive care.

The year was enormously challenging, to be sure, and it called upon us to dig deep. But we were made for times like these. Our experience has affirmed that Fenway Health is just as nimble, resilient, creative, and innovative today as we were 50 years ago—and will be 50 years from now. When committed, resourceful people of good will come together in service to a common vision, anything is possible.

Thank you for being part of the Fenway Health community.

STRATEGIC PLAN &
RACIAL EQUITY ACTION PLAN

Centering racial equity is critical to the mission of Fenway Health. We were founded to serve under-resourced and marginalized communities, and advocacy is a core component of our mission. We know that we need to do more to center racial equity and social justice in everything we do and to work to undo disparities and inequities that exist in the services we provide, the people we reach, and the outcomes we achieve.

We have committed to taking the necessary actions that will ensure that our entire organization is engaged in racial equity and social justice service delivery and practice. Everyone within our organization will be involved in this work – our Board of Directors, organizational leadership, staff, and volunteers – and we are focused on how we engage our patients, clients, and community partners as well.

As part of these efforts, we unveiled a new mission statement, Strategic Plan, and Racial Equity Action Plan at our virtual Spring Board of Visitors Meeting and Fenway@50 Annual Meeting. They were the culmination of a year-long effort evaluating our work and focusing the lens of racial justice on all of our upcoming initiatives.

At our 2021 Annual Meeting, Fenway Health unveiled our new mission statement, 5-year Strategic Plan, and Racial Equity Action Plan, all designed to make us a more just and equitable organization.

Our Mission

Strategic Plan

Read the full
plan here (PDF)

Download a one-page summary (PDF)

Adoption of 2021-2025 Strategic Plan

The Fenway Health 2021-2025 Strategic Plan was developed during 2020–2021 to cover the operating period of July 1, 2021 through June 30, 2026. The Strategic Plan was approved for adoption by the Fenway Health Board of Directors via a vote at the June 8, 2021 Board of Directors meeting, and recorded in the meeting minutes. As Chair of the Fenway Health Board of Directors, my signature affirms the Board of Directors’ approval for adoption of the 2021-2025 Strategic Plan:

Jonathan I. Matsui, PhD
Chair, Fenway Health Board of Directors

Racial Equity Action Plan

Read the full
plan here (PDF)

Download a one-page summary (PDF)

We are committed to becoming an antiracist organization. We know that we are only at the beginning of this journey. Our work will be ongoing, multidimensional, incremental, and ultimately transformative.

Over time, we will begin to look and act different: Leadership will change; How we design, implement, and evaluate our care models, research, advocacy, and services will change; The people who come to count on us, who want to work with us, who support us will change; and ultimately, Lives will change.

Holding Ourselves Accountable

Fenway Health’s Racial Equity Action plan lays out ambitious but achievable goals for the first 12 months; the next 18-30 months; and then 36-60 months. When we announced our commitment to becoming an anti-racist organization, we promised to be transparent and provide regular updates on our work and accomplishments along the way. One of the ways we will do that is on our , which we encourage everyone to visit. We’ll also be talking about this work on our blog and in messages to our staff, patients, and community from our CEO, Board Chair, and others as we continue this work.

FENWAY TURNS 50!

“No organization succeeds without providing solid answers to questions about its mission and how to achieve it. This is an organization that began by offering free health care for all, insisting that “health care is a right, not a privilege.” To fulfill this promise, it relied on donated services by doctors and other volunteers. Today, Fenway Health is one of Boston’s largest community health centers.

Diverse people have always come to this place, many of them consuming and designing health care that they believed was truly theirs for the first time in their lives. Together, these people found ways to collaborate at a medical facility that works for all. They responded to a crisis, partially prepared but always completely focused, and succeeded in impressive fashion. In a variety of ways, these people and this place give us insight into how national human service programs move from the president’s pen to neighborhood reality. And it gives us an education by real example of the answers to a series of unique questions that were at times highly predictable, and at others, completely unexpected.”

Thomas Martorelli, former Fenway Board Chair and author of For People, Not For Profit, a history of Fenway Health.

In 2021, Fenway Health celebrated 50 years of caring for our community. Founded in 1971 in the basement of a Massachusetts Avenue building owned by the Christian Science Church, Fenway now operates three clinical sites, three public health locations, and a resale thrift store chain that helps support our operations.

Originally started as a one day a week drop-in center operated by volunteer medical students, we now offer medical, behavioral health, dental and eye care, two pharmacy locations, and a number of specialized services including our Violence Recovery Program, Transgender Health, HIV and STI testing and prevention, LGBTQIA+ parenting and alternative insemination services, radiology, and COVID-19 testing, vaccinations, and care. The Fenway Institute operates biomedical, behavioral health, population level research studies, public policy and advocacy programs, and a training and education division. You can learn more about our history here.

Celebrating Our 50th Birthday

To help commemorate our 50^th birthday year, Fenway held a free virtual gala celebration on April 28, 2021. The event featured Dr. Anthony Fauci as our keynote speaker and to look back at our successes and forward to the future. The night was a resounding success, with hundreds of attendees and a silent auction and fundraising challenge that raised more than $345,000 to support care and services at Fenway Health.

Weren’t able to attend? No worries! You can watch the whole thing, including Dr. Fauci’s speech, here. (Note: Program begins around the 42 minute mark).

As part of the program, we put together four videos highlighting our work and history.

Trans Health at Fenway Health

Youth Services at Fenway Health

Fenway Health’s First 50 Years

Research at The Fenway Institute: HIV History and COVID-19 Vaccines

Thank you to everyone who helped make the night such a rousing success!

Fenway@50 Podcast Series

Fenway’s Pride in Your Health podcast series posted several interviews commemorating our 50^th year.

Pride in Our Health explores a different LGBTQIA+ health topic each episode, taking a deep dive into a wide range of important topics across health and wellness. We’ll discuss the latest care options, learn about lifesaving medical breakthroughs, and gather expert advice on how to be a happier, healthier you. You can subscribe to Pride in Our Health on iTunes, Apple Podcast, Google Play, or Spotify.

Looking To The Future

On June 10, 2021, Fenway Health held our virtual Spring Board of Visitors Meeting and Fenway@50 Annual Meeting. We unveiled a new mission statement, Strategic Plan, and Racial Equity Action Plan at both of them with the goal of centering equity and social justice in everything we do. They were the culmination of a year-long effort evaluating our work and focusing the lens of racial justice on all of our upcoming initiatives.

At our 2021 Annual Meeting, Fenway Health unveiled our new mission statement, 5-year Strategic Plan, and Racial Equity Action Plan, all designed to make us a more just and equitable organization.

Our Mission

Strategic Plan

Read the full
plan here (PDF)

Download a one-page summary (PDF)

Racial Equity Action Plan

Read the full
plan here (PDF)

Download a one-page summary (PDF)

RESPONSE TO COVID-19

The first COVID-19 case was diagnosed in the United States on January 20, 2020 and by March of that year, the pandemic had spread across the country, including to Massachusetts. Fenway Health was quick to respond and you can read more about our efforts in those early months here. Our work to care for our patients, staff, and communities continued into fiscal year 2021.

Fenway continued to expand our telehealth program while also bringing patients back onsite for important in-person care and services as vaccination became more common and infection rates in Massachusetts fell. To commemorate the one year anniversary of the pandemic, our CEO Ellen LaPointe wrote a blog post reflecting on ways Fenway adapted and continued to care for our patients an communities while also working to address the disparities in health care based on race that COVID laid bare. You can read Ellen’s message here.

The LGBT Aging Project received a grant from the Eastern Bank Charitable Foundation for COVID-19 aid. The Aging Project used this generous funding to help LGBTQIA+ older adults stay connected to their communities and support networks virtually. Many seniors continue to face increased isolation as the pandemic continues to evolve, and having the option to engage with each other through technology like Zoom has become a true lifeline.

We established a specially designed clinic space at our 1340 Boylston Street location that allows us to provide care for people who may be displaying symptoms consistent with COVID-19 or other respiratory illnesses, or who are currently infected with COVID-19. This new space ensures we can safely evaluate and care for patients who also have these symptoms.

During fiscal year 2021, Fenway Health’s COVID-19 testing program continuously evolved to meet the challenges of the pandemic and the weather.

Partnering with the Boston Public Health Commission, our COVID-19 testing was first located in a Boston Public Schools parking lot behind our 1340 Boylston Street location, then in another parking lot a short distance away at Holy Trinity Orthodox Cathedral. As winter weather moved in, we temporarily relocated our testing program to the front of 1340 Boylston Street while we built out a new indoor COVID-19 testing and respiratory symptoms clinic which opened late January of 2021.

Altogether during fiscal year 2021, 6,738 COVID-19 tests were performed by our 1340 Boylston Street testing team.

From July 20 through September 11, 2020, we also partnered with the Massachusetts Department of Public Health (DPH) to offer COVID-19 testing at several sites around the city of Everett. Through this initiative, we were able to perform an additional 4,203 tests for a total of nearly 11,000 COVID tests during FY21.

On December 22, 2020, the first COVID-19 vaccine doses arrived at Fenway and we began immunizing front line health care and public health staff. Soon after, staff at 1340 Boylston Street and Fenway: South End began vaccinating Fenway Health patients in accordance with the DPH’s vaccination phase guidelines. A few months later we opened up our vaccination program to the general public and added a temporary third vaccine clinic location at 75 Amory Street on the Jamaica Plain/Roxbury border.

As our vaccine efforts continued to expand, we started an ambassador program, enlisting non-medical staff volunteers from across Fenway to help answer patient questions and facilitate the smooth running of the vaccine clinic. This allowed our Patient Services staff members to spend more time on patient outreach and our medical providers to focus entirely on administering vaccinations and caring for our patients.

During fiscal year 2021, we administered 9,062 – 4,694 first or single doses of Moderna or Johnson and Johnson and 4,368 second doses of Moderna.

The Fenway Institute’s vaccine trial experience goes back more than 25 years, when we enrolled the first participants in anti-HIV vaccine trials funded by the National Institutes of Health. Since then, Fenway has run more than a dozen vaccine trials. Because we have a clinical trials research infrastructure in place that includes a team of experienced clinical research staff, an independent ethics review board, and a dedicated community engagement team that can recruit participants from all risk groups, we were asked to join the COVID-19 Prevention Network, the NIH’s consortium to evaluate vaccines and other promising preventive strategies, in the early days of the pandemic.

At the start of the fiscal year, we began recruiting for a study looking at COVID-19 infection and how the body recovers from that infection. A couple of months later, we launched a phase 3 COVID-19 vaccine clinical trial with the COVID-19 Prevention Network and then a monoclonal antibody study hoping to prevent COVID-19 disease among household members of recently diagnosed people. You can listen to more about the science behind the antibody study on our Pride in Your Health podcast.

Fenway partnered with Matrix Medical Network to deploy a mobile health clinic in neighborhoods around greater Boston, making it easier for people who live and work in those communities to participate in clinical trials of investigational COVID-19 vaccines. The goal of the mobile health clinic was to support efforts to ensure that Black and Latinx people are proportionately represented in vaccine clinical trials, as these groups have experienced disproportionately higher rates of COVID-19 infections and fatalities than other racial and ethnic groups.

In January 2021, The Fenway Institute concluded recruitment for the Phase 3 clinical trial of the efficacy of the AstraZeneca COVID-19 vaccine. Over the course of 10 weeks, the study team recruited 214 participants. Trial participants were 18 or over and came from a wide range of racial and ethnic backgrounds. Participants included people living with HIV and people at increased risk of infection from COVID-19. While the AstraZeneca vaccine has not yet been approved for use in the United States, it is currently being administered to people in other countries around the globe.

At the end of the fiscal year, Fenway launched the Prevent COVID U study, looking at how effective the Moderna COVID-19 vaccine is in protecting against and preventing transmission of COVID-19.

Fenway Health and over 125 organizations called upon the Association of State and Territorial Health Officers to create an inclusive and coordinated plan to distribute the COVID-19 vaccine and to make concerted efforts to reach and establish trust with LGBTQI populations. Additionally, these organizations called upon Association of State and Territorial Health Officers to include the collection of sexual orientation, gender identity, and intersex status data in their vaccine dissemination plan for LGBTQI communities in order to track and respond to issues for these communities.

In July 2020, The 23rd International AIDS Conference – known as AIDS 2020: Virtual – welcomed researchers, physicians, and advocates around the globe for the world’s largest virtual conference on HIV. Douglas Krakower, MD, Adjunct Faculty Member at The Fenway Institute and Assistant Professor of Medicine at Harvard Medical School, presented on the “Impact of COVID-19 on HIV Pre-exposure Prophylaxis Care at a Boston Community Health Center,” which looked at how the COVID-19 pandemic has affected PrEP usage and adherence among Fenway Health patients.

As COVID-19 vaccine clinical trials were being launched across the US and around the world, including here at Fenway, we published a blog post and infographic helping to explain COVID-19 vaccine trials and how vaccines work. We mailed the infographic to thousands of people in Boston area neighborhoods with traditionally underserved populations.

Later that year, the world watched as desperately needed COVID-19 vaccines began to reach the public. There are many challenges around new vaccines – research, testing, manufacturing, distribution – that can affect how quickly and effectively mass vaccinations work. But one serious hurdle is not something that can be solved in a lab: building public trust in a new vaccine.

As we have seen in the months since, disinformation around COVID-19, the unprecedented speed by which vaccines were developed and approved, and past abuses against certain communities by the medical industry are all factors contributing to public distrust of and hesitance to receive these new vaccines. To help address this, Dr. Kenneth Mayer, Medical Research Director at Fenway Health and Co-Director of The Fenway Institute, co-authored an article in the American Journal of Public Health outlining the seriousness of this moment and the critical need to reach out to these communities to build back that trust.

HEALTHCARE

Fenway Health provides high quality, comprehensive and affirming care.

At Fenway Health, we believe that health care is a right, not a privilege.

In every department, our staff is dedicated to meeting the needs of everyone who walks through our doors through integrated personal and compassionate care, regardless of their ability to pay. We offer a wide range of ever-growing services for the entire family within our clinical divisions, including medical, behavioral health, dental, vision, HIV/STI screening, pharmacy, women’s health, transgender health, alternative insemination and obstetrics, and the Violence Recovery Program. Our care and services are available at three Boston locations.

Fenway Health is affiliated with Beth Israel Deaconess Medical Center and all physicians hold faculty appointments at Harvard Medical School.We areaccredited by the Joint Commission on Accreditation of Healthcare Organizations.

In March 2020, Fenway welcomed Ellen LaPointe as our new CEO just as the COVID-19 pandemic rolled across the globe. Fenway Health pivoted to respond, moving the majority of our medical and behavioral health appointments to telehealth, standing up testing programs in Boston and Everett, and activating several COVID-19 research studies.

In fiscal year 2021, Fenway Health providers saw nearly

39,000

Patients

who made more than

194,700

Patient Visits

Medical

30,510 patients
105,031 visits

Behavioral Health

4,587 patients
46,421 visits

Dental

3,886 patients
15,451 visits

Vision

1,662 patients
2,295 visits

Numbers were affected by COVID-19 closures

Fenway Health provides care for our community and all
members of your family from three Boston locations.

The Ansin Building

The Ansin Building, a 10-story, 100,000 square foot health care and research facility. It is the largest building ever constructed by an organization with a specific mission to serve the LGBTQIA+ community.

Fenway: South End

Fenway: South End, a private practice setting for medical and behavioral health care, women’s health, and pharmacy services conveniently located for those who live and work in Boston’s South End and Back Bay neighborhoods.

The Sidney Borum, Jr. Health Center

The Sidney Borum, Jr. Health Center, quality health care for young people ages 12 to 29—many of whom are LGBTQIA+, HIV-positive, living on the streets, using drugs or alcohol, engaging in sex work or gang involved—who may not feel comfortable going anywhere else.

At Fenway, we treat the whole person.

Fenway has helped pioneer a philosophy of integrated care that looks at each patient as a whole person and our staff works as a team to meet the needs of everyone who comes through our doors.

Patient-Centered Medical Care
Fenway Health’s Ansin Building and South End locations are both certified as National Committee for Quality Assurance Level 3 Patient-Centered Medical Homes (PCMH). The PCMH model of primary care emphasizes care coordination and communication to transform primary care into “what patients want it to be.” In 2016, the Massachusetts Health Policy Commission named Fenway: South End the first practice in the state to achieve Patient-Centered Medical Home PRIME Certification for integrating behavioral health in primary medical care. Fenway’s Ansin Building Practice followed quickly, attaining PRIME Certification in early 2017.

Family Medicine
Fenway Health’s Family Medicine Program has expanded to all of our locations, allowing us to provide services to patients of every age group, from the youngest to the oldest.

Transgender Health
More than 5,100 transgender patients currently receive care at Fenway Health locations, an increase of roughly 4,000 patients since 2007. The Transgender Health Program continues to expand to comprehensively address the needs of our rapidly growing transgender and gender non-conforming patient base.

Women’s Health
Fenway’s Women’s Health Program seeks to meet the healthcare needs of all individuals who identify as women and/or have natal female anatomy, including lesbians, bisexual and transgender women; people who identify as gender non-binary; and people on the transmasculine spectrum. Our obstetrical services care program partners with Beth Israel Lahey Health to provide prenatal care for patients in all stages of pregnancy. The program also offers comprehensive birth control and emergency contraception services.

HIV Testing and Care
Fenway Health has been a community resource and safe space since the early days of the AIDS epidemic. Our health center saw the first HIV/AIDS cases in New England and, in 1985, was awarded the first HIV counseling and testing contract by the Massachusetts Department of Public Health. Today, Fenway remains one of the largest confidential HIV counseling and testing sites in the state and is New England’s largest provider of outpatient HIV/AIDS care.

In fiscal year 2021, Fenway cared for 2,247 patients living with HIV.
Fenway staff administered over 15,000 HIV tests.
100% of all those who test positive for HIV are triaged into care and services here at Fenway.
6,225 patients seeking HIV tests in fiscal year 2020 identified as men who have sex with men (MSM), with the remainder describing their HIV risks as heterosexual sex, injection drug use or occupational exposure.

Insurance Enrollment
1,286 patients visited our Financial Assistance department. Under Fenway’s health insurance enrollment program, patients without insurance can be enrolled in coverage under MassHealth, Commonwealth Care and Health Safety Net.

Fenway Pharmacy
Approximately $1.4 million in free and discounted medication was given to patients in need by the Fenway pharmacy’s two branches. The pharmacies also offer a free home delivery service for homebound patients and others unable to prick up their medication. Together, the two locations fill well over 500 prescriptions per day.

Alternative Insemination
Over 770 babies have been conceived through Fenway’s Alternative Insemination (AI) Program since its start in 1983, believed to be the first of its kind in the United States. In fiscal year 2021, the AI program saw 28 new pregnancies. In addition to insemination, the AI Program offers social and emotional support for LGBTQIA+ parents and prospective parents through a variety of workshops and groups.

Addiction Recovery and Wellness
3,049 patients were brought into care through Fenway’s Addiction Recovery and Wellness Program, which treats those struggling with substances like alcohol, cocaine and crystal methamphetamine. In 2017, the program added Problem Gambling Services. We never turn anyone away for lack of ability to pay, and many patients in the Program are referred into other services at Fenway.

Violence Recovery Program
332 survivors of domestic violence, sexual assault, hate violence and police misconduct were helped by the Violence Recovery Program (VRP) at Fenway Health. The VRP offers individual and group counseling to LGBTQIA+ survivors. VRP staff also conducts outreach and educational sessions to community groups and professional groups about LGBTQIA+ violence issues on a local, state and national level, including providing technical assistance and training to the Boston Police Department, District Attorney’s offices, hospitals, health centers, social service agencies and community and school groups.

Health Navigators
Fenway’s Health Navigators answered 2,652 calls, providing resources, support, and a friendly ear to people from all walks of life.

Interested in becoming a
Fenway Health patient?

Nearly 39,000 people in Greater Boston and from all over New England call Fenway

Health their medical home. Our award-winning, dedicated clinicians provide full-service primary and behavioral health care at three convenient locations in Boston. Find out how to become a Fenway Health patient here.

Are you a current patient and need to make an appointment?

Medical 617.927.6000

Behavioral Health 617.927.6202

Dental 617.927.6127

Optometry 617.927.6190

Fenway: South End 617.247.7555

Sidney Borum, Jr. Health Center 617.457.8140

Información En Español 617.927.6460

THE DIVISION OF EDUCATION & TRAINING

The National LGBTQIA+ Health Education Center

The National LGBTQIA+ Health Education Center provides educational programs, training, technical assistance, resources, and consultation to health care organizations with the goal of optimizing quality, cost-effective health care for lesbian, gay, bisexual, transgender, queer, intersex, asexual and all sexual and gender minority (LGBTQIA+) people. In FY2021, faculty from the Education Center presented at conferences and facilitated trainings and webinars, educating health care professionals on a range of topics from achieving health equity to care for transgender and gender-diverse patients, to care for LGBTQIA+ older adults, to affirming care for intersex patients. The Education Center also produced 13 new publications and resources in FY2021.

Online Learning and Education Offerings

174

Archived Online Webinars

20

Interactive online learning modules on LGBTQIA+ health topics

16,431

Combined total view count in FY2020

59,000

People on email newsletter list

Publications

Supportive Housing and Health Services for LGBTQIA+ Youth Experiencing Homelessness: Promising Practices

Affirming Primary Care for Intersex People

Neurodiversity & Gender-Diverse Youth: An Affirming Approach to Care

The COVID-19 Pandemic: Supporting LGBTQIA+ Patients

Sexual Health and Older LGBTQIA+ Adults

Ten Strategies for Creating Inclusive Health Care Environments for LGBTQIA+ People

Quick guide for Supporting the Behavioral Health of Sexual Minority Men

TelePrEP: Telemedicine for HIV Prevention

Medical Care of Trans and Gender Diverse Adults

HIV and Diabetes Mellitus

LGBTQIA+ Youth and Experiences of Human Trafficking: A Healing-Centered Approach

Engaging the Families of Transgender and Gender Diverse Children

Housing, Health, and LGBTQIA+ Older Adults

Conferences

Advancing Excellence in Transgender Health

On October 16–19, 2020, The Division of Education and Training at The Fenway Institute hosted the 6th annual Advancing Excellence in Transgender Health Conference. This year’s conference was held virtually and saw a record number of 578 registrants from 46 US states, Puerto Rico, Belgium, Canada, Mexico, Pakistan, the Philippines, Portugal, and Singapore. This year the conference also included an optional half-day pre-conference for those seeking additional training on the basics of gender-affirming care before the start of the general conference. The conference agenda included a variety of sessions on important topics such as ‘creating an inclusive and affirming environment,’ ‘gender-affirming hormone therapy,’ ‘behavioral health care for transgender and gender-diverse youth and adolescents’ and ‘collecting gender identity data in EHRs.’ The conference also featured four community panels. Attendees were also able to network with each other and the speakers through Q&A sessions, virtual networking events and 1:1 private messaging in the conference platform.

The Evidence-Informed Interventions Coordinating Center for Technical Assistance

In 2021, the Division of Education and Training completed its four-year initiative funded by HRSA HIV/AIDS Bureau titled The Evidence-Informed Interventions Coordinating Center for Technical Assistance (E2i CCTA). This project provided support for 25 Ryan White HIV/AIDS Program-funded recipients for the implementation of evidence-informed interventions. Its aim was to facilitate and guide recipients in their efforts to reduce HIV-related health disparities and improve health outcomes, including increasing retention in care, improving treatment adherence, and improving viral suppression for people living with HIV/AIDS.

Milestones in the Fourth Year (August 2020-July 2021) of the project included:

Provided training and technical assistance to all 25 sub-awardee organizations including conducting site visits at all 25 sites.
Hosted a Virtual Learning Session in March 2021 inviting 25 sub-awardee organizations
Completed 25 site narrative reports on the strengths and challenges, lessons learned, and ongoing intervention adaptations.
Assisted sites with collection of data to provide to the Evaluation Center for analysis.
Developed tool kits for ongoing dissemination.

The LGBT Aging Project

In FY21 The LGBT Aging Project rebranded as the LGBTQIA+ Aging Project, consistent with Fenway Health’s expanded definition of the populations we serve. The LGBTQIA+ Aging Project focused much of its FY21 year work on response to COVID 19 and its impact on older alder adults. Staff and volunteers conducted nearly 600 outreach calls to LGBTQIA+ older adults in Massachusetts. The LGBTQIA+ Aging Project also convened a weekly Zoom Drop-In group to reduce social isolation and loneliness. The group met on Thanksgiving and Christmas to reduce isolation. In late 2020, the group expanded to meeting twice weekly, with a total registration of 75 participants. The LGBTQIA+ Aging Project convened monthly summits for a dozen organizations, providing training on virtual programming for LGBTQIA+ older adults so these organizations could improve their efforts to engage with and sustain relationships with LGBTQIA+ older adults. Throughout FY21, the LGBTQIA+ Aging Project conducted 40 trainings, workshops, and webinars for a total of 620 participants including three national and two local conferences. The LGBTQIA+ Aging Project also co-hosted the 10th annual LGBT Elders in an Ever-Changing World Conference, New England’s premier LGBT Aging Conference, for 256 participants (local, national, and international). The LGBTQIA+ Aging Project launched a Transgender and Gender Diverse Engagement Initiative reaching nearly 50 new people between the ages of 50-70. It hosted three bereavement groups for LGBTQIA+ people of all ages who have lost a loved one. In FY21, the LGBTQIA+ Aging Project also continued its leadership on the Massachusetts LGBT Aging Commission.

Partnerships

The Division of Education and Training partnered with many organizations to provide trainings on LGBTQIA+ health. Some of these partners include:

UCLA

Working with theDMH-UCLA Prevention Training Center of Excellence, the Division of Education and Training developed an online learning module that was distributed to staff across Los Angeles County. The course includes case scenarios that staff can use to practice responding to real situations they may encounter.

UPMC

The Division of Education and Training worked with University of Pittsburgh Medical Center (UPMC) to develop an application process for medical providers to obtain an LGBTQ+ Affirming Provider Designation in their member-facing provider directory including three educational modules. The modules were on “Introduction to Affirmative Care for LGBTQ+ Individuals,” “Health Care for Transgender and Gender Diverse Populations,” and “Sexual Orientation and Gender Identity Affirming Documentation and Systems.”

Children’s Omaha

In collaboration with Children’s Omaha, the Division of Education and Training developed an interactive learning module on “Achieving Equity for Lesbian, Gay, Bisexual, Transgender and Queer (LGBTQ) People.”

RESEARCH

The Fenway Institute is one of the preeminent LGBTQIA+ health and HIV research organizations in the world.

Fenway researchers and educators are frequently published in:

The New England Journal of Medicine
The Journal of the American Medical Association
The Lancet
The American Journal of Public Health
Clinical Infectious Diseases
Other major journals to educate the professional and lay communities about key LGBTQIA+ and HIV health issues
National print, television, online, and other news

Our faculty present at national and international meetings and conferences including:

The International AIDS Society
The American Public Health Association
The Gerontological Society of America
The Population Association of America
HIV Research for Prevention
Advancing Excellence in Transgender Health
Advancing Excellence in Transgender Health
Conference on Retroviruses and Opportunistic Infections
WPATH Scientific Symposium

Biomedical Research

During fiscal year 2021, The Fenway Institute’s Biomedical Research team continued to conduct clinical trials looking at new approaches to preventing HIV infection. As well as expanded to COVID-19 research on infection and transmission. Populations include both Adult and Adolescents. Our recruitment and outreach team has worked to represent Fenway at Pride Events in Massachusetts, World AIDS Day, organizations such as the Multicultural AIDS Coalition, Boston Lesbigay Urban Foundation, MA Commission on Youth, NAGLY, and BAGLY as well as at presentations at local colleges and universities throughout the year. As COVID-19 forced many events to move online, research staff adapted to move their events online and to represent Fenway at virtual events organized by other community organizations.

The Fenway Institute has operated one of the nation’s first federally funded community-based HIV research programs and has been a site for NIAID network research since 1993. As an active site for the HIV Prevention Trials Network (HPTN) and participating in protocols in the HIV Vaccine Trials Network (HVTN).

The Fenway Institute has participated in key HIV prevention efficacy trials that led to internationally significant breakthroughs, such as the iPrEX study, the first to demonstrate the efficacy of PrEP in preventing HIV infection. More recently, we participated in the DISCOVER trial that demonstrated a second oral medication is effective as PrEP and the recently completed HPTN 083, which demonstrated the efficacy of an injectable medication for PrEP for the first time ever. Since March 2020, The Institute has been deployed to work on COVID-19 research as part of the NIH Coronavirus Prevention Network (CoVPN).

Fenway completed the first CoVPN study in January 2021 and is now conducting clinical trials to understand COVID-19 transmission.

Phase I HIV prevention and vaccine studies

HVTN 117
HVTN 117 examines both tolerability and the immune system’s response to a new HIV vaccine. HIV Vaccine study in healthy adults, HIV uninfected, ages 18–50. No longer currently enrolling, in active follow up.

HPTN 089
In 2021, The study activities are complete and pending closure. The study explored 4 HIV antibodies in different combinations. The antibodies in HPTN089 are in the first phase of research; it is not an efficacy trial. Participants receive one infusion and participate in the study for 18 months.

HVTN 124
HVTN 124 examines both tolerability and the immune system’s response to a new HIV vaccine. This vaccine is made using laboratory products that look like HIV to generate an immune response. It is impossible for the vaccine to give someone HIV. Participation for this study includes 12 visits over the course of about 18 months.

HPTN 133
This phase I clinical trial to evaluates the safety and immunogenicity of an HIV-1 MPER peptide liposome vaccine in healthy, HIV-uninfected adult participants. Participants will attend several study visits through Month 12. All activity is completed and unblinding is pending.

HPTN 092
HPTN-092 tests the tolerability, safety, and the immune system’s response to combinations of experimental HIV antibodies. Participants are 18–50 years, HIV uninfected of all genders and sexualities. Actively enrollment is closed, we have one participant in follow up.

Phase 3 HIV prevention and vaccine studies

HPTN 083
Fenway was the only center in New England to enroll participants in HPTN 083, which evaluated injectable cabotegravir given every 8 weeks after 2 loading doses 4 weeks apart compared to daily oral tenofovir/emtricitabine to prevent HIV acquisition in MSM and transgender women. The initial study demonstrated the superiority of injectable cabotegravir, which led to FDA approval, and participants are now being followed to see if the prevention benefit is maintained over time.

HVTN 706
Currently we are enrolling for a Phase 3 HIV Vaccine study called MOSAICO testing for the safety and efficacy of an investigational vaccine. MOSAICO is the third HIV vaccine efficacy trial in progress worldwide. This trial will enroll 3,800 HIV-negative men and transgender people aged 18 to 60 years who have sex with men and/or transgender people. Clinical research sites are in the US, Argentina, Brazil, Italy, Mexico, Peru, Poland, and Spain. Enrollment has recently closed.

Project AMP
Project AMP studied whether a broadly neutralizing antibody (bnAb) called VRC01 was effective at preventing the acquisition of HIV strains that were sensitive to the bnAb. This was assessed by a laboratory test that measures a virus’ susceptibility to neutralization by an antibody. Although overall, the use of the antibody did not protect against HIV in the primary analysis, a subset of patients with viral strains that were more susceptible to neutralization by the antibody achieved some protection from HIV infection. This finding is helping to inspire studies of combinations of antibodies that may provide better protection against HIV.

Coronavirus Prevention Studies

Observational

HVTN 405

The purpose of this study is to learn more about infection with and recovery from the virus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Some people know this virus by the name “coronavirus.” It can cause the disease called COVID-19. The information gained from the study will be used to help develop better tests for SARS-CoV-2 infection and COVID-19 disease and may help in developing future vaccines and treatments by allowing researchers to determine the difference between the body’s immune response to natural SARS-CoV-2 infection and immunization with a SARS-CoV-2 vaccine. Enrollment is closed and all study activities at our site have been completed.

Prevention

CoVPN 3002
The COVID-19 Vaccine study is testing how safe and effective the vaccine is in protecting against COVID-19. Participants may be eligible if they are 18 years or older and have tested negative for COVID-19. There are 10 or more visits over the span of 1-2 years. Enrollment closed, active follow up with over 200 participants.

CoVPN 3502
The COVID-19 Household study is testing how safe and effective the treatment is in protecting people against COVID-19 exposure. Participants may be eligible if they are 18 years or older and have tested negative for COVID-19. There are 12 visits over the span of 10 months. Enrollment closed, active follow up 7 people completed.

CoVPN 3006
PreventCOVIDU is a study across the US to learn whether the Moderna COVID-19 vaccine stops the spread of the SARS-CoV-2 virus: both getting infected — even without symptoms — and spreading it to others. Participants may be eligible if they are 18–29 years old and have tested negative for COVID-19. There are 5 visits over the span of 5 months. The study is actively enrolling.

Youth and Adolescent Studies

MyChoices
The MyChoices study is an intervention investigating the feasibility and acceptability of MyChoices, a theory-driven mobile app to increase HIV testing and PrEP uptake by young men who have sex with men (YMSM), ages 15-24. The MyChoices app was refined in theater testing and an open technical pilot. The acceptability and feasibility of the updated app was evaluated in a pilot randomized controlled trial (RCT) among YMSM at risk for HIV acquisition in the US. Phase III (RCT) opened to accrual in October 2018 and participant follow-up completed in November 2019. The cohort was fully enrolled with 60 participants on April 2019.

LifeSteps for PrEP for Youth
The ATN’s LSPY protocol entails a two-phase study exploring PrEP adherence through a Cognitive Behavior Therapy based intervention. The first phase includes individual, qualitative interviews with approximately 20 YMSM and 10 key informants for intervention adaptation and refinement. The second phase is a pilot randomized controlled trial (RCT) of up to 54 YMSM to assess feasibility, acceptability and preliminary efficacy of the LSPY compared to standard of PrEP care only to improve PrEP adherence. Our long-term goal is to develop scalable protocols to optimize at risk YMSM’s PrEP uptake and adherence in order to decrease HIV incidence. The adaptation for LifeSteps for PrEP for YMSM will be informed, developed, and refined through formative research that involves YMSM at all levels. Phase 1 has been completed, and enrollment of the pilot RCT began in September 2019. Currently, at Fenway, the study has exceeded its target recruitment number but is still open to enrollment for young cisgender men who are recent and first-time users of PrEP.

P3
P3 is a three arm, randomized-controlled trial (RCT) that tested the efficacy of the P3 app. P3 is a novel, theory-based mobile app that utilizes game mechanics and social networking features to improve PrEP adherence, retention in PrEP clinical care and PrEP persistence among young men who have sex with men (YMSM) and trans women who have sex with men (YTW), ages 16-24. The study is testing the efficacy of P3 and P3+, which adds Next Step Counseling delivered by an adherence counselor through the app, against PrEP standard of care. Participants will be randomized to P3, P3+, or standard of care. A cost comparison between P3 and P3+ will be conducted. Enrollment for P3 began in May 2019 and recently closed in August 2021.

COMPARE
In years 1-3 of the iTech branch of the Adolescent Trials Network, we have optimized and pilot-tested, using a similar study design and identical study outcomes, two distinct mobile apps, LYNX and MyChoices. The apps are designed to increase HIV testing and PrEP uptake among YMSM. The apps were developed based on different theories of behavior change, and therefore contain different components, differing messaging strategies and different approaches for engaging youth. The individual apps will be tested simultaneously in this follow-on research study to evaluate for efficacy; participants will be randomized to receive LYNX, MyChoices, or Standard of Care. Comparing the apps will allow us to identify any efficacy differences in increasing HIV testing or increasing PrEP uptake between the two apps. If justified, we will combine the components of each app that have the greatest impact on behaviors into a final, composite app for dissemination. Enrollment for COMPARE began in September 2019 and is still currently enrolling, HIV uninfected, cisgender men who have sex with men between the ages of 16-29.

TechStep
TechStep is a three-condition, technology-based randomized controlled trial (RCT) focused on stemming HIV and sexual health risk in trans youth. The study utilizes aa stepped care approach where, if deemed necessary, some participants are stepped up to be randomized to receive counseling from an in-app eCoach to discuss issues of trans health and sexual health. The study focused on enrolling high-risk HIV-negative trans feminine, trans masculine, and gender non-conforming youth with the intent to reduce sexual risk behaviors (e.g., condomless anal intercourse, engagement in sex work, sex while feeling the effects of alcohol or drugs) and increasing PrEP uptake. Enrollment for TechStep began in September 2019 and ended in September 2021.

Injectable PrEP for Youth
In continuation of our decades-long commitment to treating and preventing HIV/AIDS, Fenway Health is a testing site for another study that explores whether injectable cabotegravir is an effective method for PrEP in youth (people under 18 years old.) The parent study of Injectable PrEP for adults was proven safe and effective. Just as safe, if not more than Truvada.

Youth ages 13-24 make up 21% of new HIV infections (CDC, 2017). Having the option of taking a pill every day or receiving an injection every 8 weeks allows the individual to make the right decision for themselves. We don’t want to leave youth behind in the development of new HIV prevention methods. Enrollment for Injectable PrEP for Youth started in April 2, 2020 and is still currently enrolling.

Other Biomedical Research Studies

PrEP @ Home
The Fenway Institute continues to enroll for the PrEP @ Home Study, a trial of a home-based system of PrEP care that involves mail-in STI and HIV testing, as well as video conferences with a study provider. Since participants must be new to PrEP in order to be eligible, our research recruitment team has worked hard to develop new, creative outreach strategies to reach people not already engaged in PrEP care. Actively enrolling.

LifeSteps PrEP Adherence Study
Fenway Health, in conjunction with the University of Miami, is conducting research to investigate new ways to help adults stick to their daily PrEP regimen. Participants must be new to PrEP, 18 years or older, assigned male at birth and have sex with men. Actively enrolling.

Merck PrEP User Acceptability Study
The Merck PrEP User Acceptability study is two-phase project sponsored by Merck & Co, Inc. The purpose of this study is to understand how young men who have sex with men ages 18 to 34 feel about current and upcoming ways to take HIV PrEP. including implantable and less frequent dosing, and which ones they use and why. As new methods of preventing HIV are developed, we want to hear the thoughts YMSM have about them. In phase 1, through focus groups, we hope to learn their thoughts about a variety of long-acting PrEP agents, including monthly pills, injections, and implantable rods. Participants will also be asked to share their knowledge about oral PrEP, long-acting PrEP agents, PrEP stigma, PrEP costs, and whether long-acting agents might enhance retention in PrEP care and adherence to PrEP guidelines. In phase 2, we will conduct a multi-regional quantitative survey to assess the same questions within a larger popualtion. The User Acceptability study will begin enrolling Fall 2021.

Behavioral Sciences Research Program

HIV and Behavioral Health Treatment [HIV]

Project Matter
Project Matter is a refined text-enhanced psycho-behavioral randomized control trial to reduce under-addressed and modifiable barriers to engagement in HIV care, including internalized stigma and related emotions, among HIV-positive men who have sex with men who use substances and are sub-optimally engaged in HIV care. The project is funded by NIDA and aims to elucidate behavioral and social mechanisms associated with substance use and optimize treatment success among this population.

PrEPsteps
PrEPsteps is a study funded by the National Institutes of Health to build and test a smartphone-based PrEP adherence system that responds to adherence data collected through a novel digital pill, with a focus on improving PrEP adherence among who have sex with men (MSM) who use stimulants.

DigiPrEP
DigiPrEP is a Gilead Sciences-funded study to test the use of a digital enabled PrEP (DigiPrEP) to measure PrEP adherence in men who have sex with men (MSM) who use substances other than alcohol.

The Algorithm Study
The Algorithm Study provides smoking cessation pharmacotherapy recommendations integrated into HIV primary care for people living with HIV who smoke cigarettes.

Project QUIT
Project QUIT is a behavioral intervention to treat anxiety and depression and to increase rates of smoking cessation among people living with HIV who smoke cigarettes.

National HIV Behavioral Surveillance (NHBS)
National HIV Behavioral Surveillance (NHBS) was conducted by Fenway Health in conjunction with the Massachusetts Department of Public Health and Centers for Disease Control and Prevention. The goal of NHBS is to help establish and maintain a surveillance system to monitor selected risk behaviors, HIV testing, prevention services, and HIV prevalence among groups at highest risk for HIV infection. NHBS completed 2021’s MSM cycle using a hybrid remote/in-person model, with a focus on Men who have Sex with Men in the Boston area.

MaxM
MaxM is a study that aims to learn from the experiences of young Black men who have sex with men. MaxM seeks to design a program specifically for this group to help protect their sexual health and wellbeing.

Epidemiological Research

LEGACY Project
The LEGACY Project is a longitudinal cohort of Fenway transgender and gender diverse patients. In fiscal year 2021, The Fenway Institute had 5,811 patients whose electronic health record (EHR) data is included in the cohort. Of those patients, 1,377 completed an additional survey that helps fill in the gaps in EHR data. This allows the Epidemiology team to look at more extensive psychosocial factors and patient experiences with hormones, surgeries, and other gender-confirming treatment. LEGACY’s enrollment recently ended.

LITE Study
The LITE study is a longitudinal cohort of HIV-negative transgender women spanning the Eastern and Southern US. Enrollment closed at the end of August 2020; a total of 159 enrolled at Fenway. All participant study visits have continued to be done remotely. Participants are mailed at-home HIV and STI testing kits by Molecular Testing Labs and complete follow-up surveys either online, on the study app, or over the phone every three months. Participants are followed for a total of four years.

LITEPlus Study
The LITEPlus study is a longitudinal cohort of Black and/or Latina transgender women that looks at the effects of stress on cardiovascular health. Study enrollment is ongoing; a total of three individuals have enrolled at Fenway. For much of FY21, study enrollment was done remotely, but as of June 2021, in-person enrollment has resumed..

Life+Health
Life+ Health is a population-based study of patients at Fenway Health, Mattapan Community Health Center, and Harvard Street Neighborhood Health Center (in partnership with Harvard T.H Chan School of Public Health) that aims to advance methods to measure and analyze explicit and implicit discrimination in population health research. In FY21, 538 Fenway patients enrolled in the study (560 total).

Project IMPACT
Project IMPACT is a longitudinal cohort study to test a behavioral intervention created for men who have sex with men who use stimulants (meth, cocaine, crack) in the context of sex. In FY21, 19 participants were enrolled.

PrEP for Health
PrEP for Health is a randomized control trial study being carried out in the context of two community-based syringe service programs in Massachusetts (ACCESS Drug User Health Program and the Greater Lawrence Family Health Center) that uses a health navigator-based strategy and motivational interviewing to increase PrEP uptake and adherence among people who inject drugs, a population at high risk for HIV. The study began enrollment in September 2021 and, to date, participants are starting to complete their three-month assessment milestone in the study. Across both sites, 38 people have enrolled to date.

Data and Health Informatics

The Fenway Institute supports clinical, research and public health services through state-of-the-art health informatics and data systems. Fenway’s Informatics and Data Center continues to be a leader among Community Health Centers in developing data capacity and Health Information Technology (HIT) innovations.

We continue to refine our integration with Electronic Patient Reported Outcomes (ePRO) enabling us to develop algorithms to better meet the clinical needs of patients and quality measures. They provide consultation and technical assistance on federal initiatives and to federal agencies and CHC’s on HIT, data management activities that streamline and improve data capture and reporting processes. Our Data Center collaborates with other departments to provide clinical, financial and productivity data.

The Center quickly developed and implemented technologies in response to COVID-19. As a result, Fenway was able to rapidly pivot to Telehealth to reach some of the most vulnerable populations. We are currently using telehealth for clinical care, research and public health initiatives. We collaborated with a vendor to develop automating the reporting of COVID-19 negative results to patients using text messaging.

The Center worked closely with athenaHealth, our Electronic Health Records (EHR) vendor, to develop a product called ‘Centricity Now’ that will enable hospitalists and on-call providers to access to patient records wherever they are. We also work with other HIT vendors on initiatives using latest technologies to improve patient communication and health outcomes. For example, Fenway has collaborated on a project developing standards for using FHIR to transmit social determinants of health data. Additionally, we conduct webinars and in-person trainings around the US on SOGI implementation and analyzing outcomes.

The Data team has produced over 75 data analysis sets from our EHR focusing on LGBTQ patients and continues to advise other EHR vendors on refining their products to meet the needs of the LGBTQIA+ patients. It also collaborates with national and federal partners to develop tools to monitor health outcomes; for example, Fenway worked with NACHC and CDC to evaluate a Hepatitis C Care Cascade. The Center participates in many national data registry projects, whose funders include NIH and PCORI. These projects combine de-identified patient data into a shared clinical database to evaluate patient outcomes in real world settings.

C-NICS
The Centers for AIDS Research (CFAR) Network of Integrated Clinical Systems (CNICS) research network integrates longitudinal clinical data and treatment management of persons living with HIV (PLWH) and provides research infrastructure to support HIV-associated clinical, social, behavioral outcomes, and comparative effectiveness research using data collected from 8 Centers for AIDS Research clinical sites across United States. CNICS has reviewed over 180 concept studies to date, resulting in over 350 peer reviewed manuscripts and over $125M in external funding awards to investigators working in CNICS.

Since 2001, more than 2,800 patients at Fenway Health have enrolled into C-NICS and over 15,000 individual blood specimens have been collected and processed for the biological specimen repository.

NA-ACCORD
An NIH-funded data registry that is a regional collaboration of single-site and multi-site cohorts that includes over 90,000 patients from more than 50 sites throughout the United States and multiple provinces in Canada. Comprised of both academic medical centers and community-based facilities that deliver HIV-primary and specialty care, this registry combines classical epidemiological and clinical HIV cohorts, includes both HIV-seropositive and seronegative persons, and is complemented by specimen repositories for conducting translational research.

PCORnet & ADVANCE
Of the 12 national networks that make up PCORNet, a patient-centered data registry that helps answer questions important to patients, Fenway Health contributes data quarterly to the ADVANCE network. ADVANCE is the nation’s largest safety-net community laboratory, consisting of researchers, patients and clinicians. ADVANCE’s is currently composed of 7,027,332 patients, 172 health systems, 31 states, and 1,607 clinic sites. Since the beginning of pandemic in 2020, Fenway has also been contributing weekly COVID-19 related data to ADVANCE.

EVERYWOMAN
EVERYWOMAN is examining the impact of the Affordable Care Act (ACA) and state level reproductive health policies on the full spectrum of women’s health care provision and health experiences in safety-net populations. EVERYWOMAN applies a mixed-methods approach comprising patient-level electronic health record (EHR) data for large scale quantitative analyses, qualitative observations, and semi-structured interviews with patients and providers to understand perceptions and patterns of care delivery and utilization, and review of state-level reproductive health policies in inform our analyses.

Findings from this study will identify practice and policy efforts to strengthen the provision of timely, effective, evidence-based reproductive health care. Study findings will impact patients and providers through relevant practice and policy changes to improve health outcomes and reduce disparities among low-income vulnerable populations of women.

PROSPER-HIV
The PROSPER-HIV study is examining the effect of physical activity and dietary intake as effective symptom management strategies for people living with HIV (PLWH), who experience a disproportionately high symptom burden (e.g., fatigue, insomnia, pain) with few treatment options. For this three-year NIH-funded study, 850 PLWH across three CNICS sites (115 at Fenway Health) will complete an annual series of physical activities and dietary recall interviews. Additionally, participants are asked to wear a fitness tracking device to monitor physical activity routines for a week.

Marijuana Policy Change:
This is a three-phase qualitative investigation examining the role that legalization and policy changes around marijuana possession and consumption impact attitudes and patterns of use of marijuana, alcohol, and tobacco products among people living with HIV (PLWH).

Four of the C-NICS-affiliated CFAR sites are seeking to enroll 90 participants, who will participate in interviews, focus groups, and questionnaires. The results collected from this study will seek to understand changing patterns and potential consequences of marijuana and other substance use, strengthen tailored substance use interventions, and inform future policy.

In this past year, staff at The Fenway Institute completed their target of 12 remote concept interviews. After the phase one data is analyzed, we will continue to enroll participants for the second and third phase of this study.

Transgender Patient Engagement in Biomedical Research

Transgender patient participation is greatly underrepresented in biomedical research. To better understand the barriers associated with study engagement, 15 Interviews with transgender patients who have and have not participated in biomedical research. Additionally, 15 interviews with clinical staff involved in providing care or recruiting transgender patients to biomedical research will also help to determine what gaps exist for the recruitment of this population, and whether additional training or other skills may be useful to assist with study recruitment of this patient population. Recruitment for this study will begin in September 2021.

PCORI-SOGI
This 3-year study involves 12 CHCs across the country that are part of, and extended from, the HRSA-established Community Health Applied Research Network (CHARN). The primary goal of this PCORI-funded intervention study is to evaluate the impact of a sexual orientation (SO) and gender identity (GI) data collection training for Community Health Center (CHC) staff on health outcomes for sexual and gender minority patients (SGM).

Health center data from all 12 sites over the 3-year study period, informed by HRSA’s Uniform Data Systems standardized reporting system that provides consistent information about health centers and look-alikes, has now been collected. We are currently analyzing the post-intervention data to assess whether the intervention affected health outcomes for SGM patients. Key informant interviews with CHC staff are being analyzed to determine barriers and facilitators associated with collecting SOGI data. Post-intervention survey data collection from CHC patients is nearly complete and these data will be compared with pre-intervention survey data in order to explore whether the intervention impacted SGM and non-SGM patients’ health care experiences.

PUBLIC HEALTH PROGRAMS

AIDS Action is the public health division of Fenway Health and our services are designed for those most vulnerable to HIV/AIDS.

We empower our clients to live better lives by engaging with them to create practical, workable strategies to reduce their risk of HIV infection. We also assist clients with getting tested for HIV and obtaining medical care, housing, and access to benefits offered by state and federal agencies. As a result, our clients are more likely to know their HIV status, connect with the health care system, and keep themselves and their families safer from HIV infection.

Services for people living with and at risk for HIV.

AIDS Action works to support people living with HIV/AIDS, improving their quality of life and increasing treatment adherence, which helps their individual health and the broader public health by reducing the likelihood of transmission. AIDS Action provides a comprehensive set of services for People Living with HIV in order to support their access to medical care and help them achieve HIV viral suppression.

During FY2021, Fenway Health’s AIDS Action division saw:

2,312

Clients

1,190

were living with HIV/AIDS

Public Health Prevention Programs

Access Drug User Health Services

As one of several state-sanctioned and state-funded syringe exchange programs in Massachusetts, the Access Drug User Health Program distributes and exchanges syringes to people who inject drugs. Access Drug User Health Program is one of the state’s pilot sites for the distribution of Narcan, a nasal spray provided to IDUs and their network of supportive family and friends to reverse potentially fatal overdoses.

Starting in early December the Access Program has started to pilot a low barrier medical clinic to offer wound care, treatment for Hepatitis C and other STIs, linkage to nPEP/PrEP, linkage to medication assisted treatment and more. The clinic is currently open twice weekly (Wednesday and Friday 9-12) and offers walk-in availability.

Below are the current service offerings available at Access Drug User Health:

Harm Reduction supplies including injection supplies and safe smoking materials
Overdose prevention
- Individual Narcan training
- Narcan distribution
- Group Narcan trainings for businesses/organizations or anyone interested in overdose prevention
- Overdose aftercare
HIV/HCV/STI testing, treatment and linkage to care
- nPEP/PrEP
Linkages to Medication Assisted Treatment (MAT)
Twice weekly Medical Clinic (walk-in availability)
Walk-in Behavioral Health Hours

313,359

Sterile syringes distributed

393,360

Used syringes collected

463

overdoses reversed and lives saved through Naloxone distribution

HIV, HCV and STI Testing and Prevention

We deliver HIV, hepatitis C, and STI confidential testing and counseling services within our targeted prevention programs. During fiscal year 2021, we conducted 1,027 HIV tests among men who have sex with men (MSM), transgender and non-binary people, and people who inject drugs. We identified 5 new cases of HIVand reengaged 64 previously diagnosed, out-of-care HIV positive individuals back into HIV medical care.

1,027

HIV tests conducted

Sexual Health Services

The sexual health program provides testing and treatment for HIV/HCV and STIs (chlamydia, gonorrhea and syphilis) to men who have sex with men (MSM), transgender individuals and sexual partners of those populations. As part of our engagement process, we ran several virtual events during in FY2021 to highlight issues of testing and the use of PrEP, these included the “World AIDS Day ‘What to Expect When Getting Tested’” video event, the “Transgender Retreat,” and “PrEPped for the Holidays.”

Additionally, our Linkage to Care Coordinators help navigate newly identified HIV-positive individuals to medical care, reengage individuals who may have fallen out of care, assist with insurance needs, and more. Health Navigators provide PrEP (pre-exposure prophylaxis, an HIV prevention medication) education and help connect at-risk individuals to providers who can prescribe PrEP.

In fiscal year 2021, 76 clients were provided PrEP adherence support and the program was able to engage 531 MSM under 30, one of the groups at highest risk of becoming infected with HIV.

Housing

Stable housing is a critical factor in the success of people living with HIV getting connected to and staying in care. Housing staff support clients with housing search, rental and utility assistance, and housing stabilization support.

The Housing Search Program connects clients to a range of housing options, including transitional, permanent, congregate, and scattered site housing units. Our supportive housing programs provide subsidies and supportive services to families and individuals living with HIV who are exiting homelessness. The Rental Assistance Program delivers short-term emergency assistance to clients who face eviction or unaffordable housing, need assistance with move in costs and need assistance with high utility bills to avoid shutoff. In fiscal year 2021, we helped 832 households impacted by HIV move to stable housing or avoid homelessness through one or more of these housing options.

832

Number of households affected by HIV that the Housing program assisted (total clients)

35

Permanent client placements through
Housing Search and Advocacy

Legal Services

The Legal Services Department provides legal direct representation and legal advice in a variety of civil matters to people living with HIV/AIDS. In FY21, Legal Services took on 189 legal cases, which covered a wide range of client needs, including civil matters such as housing and rental disputes, public benefits, financial and end-of-life planning, and more. The goal of the department is to advocate for the legal rights of those living with HIV/AIDS throughout Massachusetts. We believe that access to legal services allows our clients to live healthier and safer lives.

189

Legal cases taken on by Legal Services in FY21

Youth on Fire

Youth on Fire is a program for homeless and street-involved youth, ages 14 – 24, which operates a safe and warm drop-in center that provides access to everything from hot showers, meals, and laundry to mental health and medical care and services. We also run a housing program that helps to get young adults off the streets and into safe housing situations so they can start rebuilding their lives.

187 homeless or unstably housed young people received services from Youth on Fire in fiscal year 2021. When the program was forced to temporarily close its drop-in center in 2020 due to COVID-19, they began offering virtual groups and connection to life-saving resources through information update regularly on their Facebook page as well as online and telephone outreach.

187

Young people received services from YOF in FY21

ADVOCACY

By publishing policy briefs, submitting public comment and testimony, writing op/eds, participating in media interviews, and joining coalitions in partnership with other institutions, Fenway Health staff and affiliated researchers and scientists engage in broad efforts to advance and disseminate LGBTQIA+ and HIV-related health policy research.

3,300 News Stories

During fiscal year 2021, Fenway programs, publications, staff experts, and events were featured in nearly 3,300 news stories, including in outlets like:

Highlights of our policy work included the following:

July, 2020

Fenway submitted Public Comment to the Office of the Assistant Secretary for Financial Resources; Health and Human Services on a proposed rule by the Department of Health and Human Services titled “Office of the Assistant Secretary for Financial Resources; Health and Human Services Grants Regulation.” Fenway expressed opposition to the proposed rule because it “would remove regulatory provisions that explicitly prohibit organizations that receive HHS grant funding from discriminating on the basis of sexual orientation, gender identity, sex, and religion. Under this dangerous and exceptionally broad rule, LGBT people, women, people of minority faiths, and non-religious people could face discrimination by a wide range of health and social service agencies that receive funding from HHS. This would put the health and well-being of millions of Americans at risk.”
Fenway submitted a letter to the Office of Minority Health and Health Equity at the Centers for Disease Control and Prevention (CDC) and the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention following up on a conversation that representatives from both offices had with Sean Cahill, PhD, the Fenway Institute’s Director of Health Policy Research. Fenway wrote to express interest in engaging “the Health Equity Task Force created by the CDC Foundation and the Satcher Health Leadership Institute regarding sexual orientation and gender identity (SOGI) data collection and reporting in the COVID-19 pandemic.”
Fenway Health signed a coalition letter to the Massachusetts House Speaker and Senate President organized by the Massachusetts chapter of the American Civil Liberties Union urging passage of “An Act to Save Black Lives” and “An Act to Secure Civil Rights.” Both measures would put systems in place to hold law enforcement accountable for violence and abuse.
Fenway Health signed a coalition letter to the Massachusetts House Speaker and Senate President organized by the Massachusetts Coalition for the Homeless urging an increase in funding for Residential Assistance for Families in Transition (RAFT) to $50 million. RAFT is a state-funded homelessness prevention program administered by the Massachusetts Department of Housing and Community Development.
Fenway Health signed a coalition letter to the Massachusetts Governor, House Speaker and Senate President organized by the Housing = Health Working Group urging passage of “An Act enabling local options for tenant protections.” The bill would give municipalities the authority to cancel rent debt and enact rent control ordinances.
Fenway Health submitted testimony to the Massachusetts Senate Ways and Means Committee in support of “An Act relative to preventing overdose deaths and increasing access to treatment.” Known as Aubri’s Law, the bill would establish a supervised consumption site pilot program in Massachusetts.
Fenway Health submitted testimony to the Massachusetts House Speaker and the Chair of the House Ways and Means Committee in support of an amendment to current state law addressing prescription co-pay assistance. That law, enacted in 2012 has a sunset provision that would, when put in place, remove co-pay assistance. The sunset provision has been postponed numerous times. The amendment would permantly remove the sunset provision from state law and ensure uninterrupted patient access to copay assistance.

August, 2020

The Fenway Institute presented at the International AIDS Conference on “Adolescent MSM’s Experiences and Perspectives of Sexual Health and HIV Prevention Access: Findings from Online and In-Person Focus Groups with Youth from across the United States.”
Fenway Health signed a coalition letter to MassHealth organized by the Association for Community Health Improvement led by the Massachusetts Public Health Association supporting changes to the state’s 1115 Demonstration Waiver from the U.S. Centers for Medicaid and Medicare. The proposed changes would support data collection for equitable outcomes, coordinate service delivery and data sharing across state agencies, and support community health workers.
Fenway Health signed a coalition letter to the Commonwealth’s Secretary of Health and Human Services organized by the Massachusetts Public Health Association’s COVID-19 Equity Task Force requesting that funds from the Federal Emergency Management Agency be used to implement the state’s “Safer-at-Home” Advisory by ensuring that all individuals and families experiencing homelessness have a place to shelter safely through the the COVID-19 pandemic.
Fenway Health signed a letter to the state legislature organized by the RaiseUp Coalition supporting an increase in taxes on corporations to generate revenue to support an equitable recovery from the COVID-19 pandemic.

September, 2020

Fenway submitted public comment to the Committee on Equitable Allocation of Vaccine for the Novel Coronavirus; National Academy of Medicine; National Academies of Sciences, Engineering, and Medicine in support of a draft “Preliminary Framework for Equitable Allocation of COVID-19 Vaccine.” Fenway wrote to support the draft document’s focus on mitigating the “negative effects of existing health inequities on the transmission of and harms from the novel coronavirus.” Fenway also wrote to request that more attention be paid to “health inequities and enhanced risk affecting LGBTQ people, which intersect with racial/ethnic and socioeconomic inequities.”
Fenway submitted public comment to the Massachusetts Legislative COVID Health Equity Task Force requesting “that the task force include sexual orientation and gender identity (SOGI) data collection and reporting in real time.” Fenway noted the need for this data collection “in order to understand how LGBTQ disparities in the COVID-19 pandemic intersect with race/ethnicity and other factors, and assess the impacts on all vulnerable populations.”
Fenway Health signed a letter to the Governor organized by the Massachusetts Right to Counsel Coalition supporting $6 million in funding to establish an emergency statewide right to counsel pilot program for low-income tenants and homeowners in eviction proceedings.
Fenway Health submitted testimony to the Massachusetts House Speaker and the Chair of the House Ways and Means Committee in support of the Healthy Youth Act, which would require school districts that teach sexuality education to use a curriculum that is evidence-based and LGBTQIA+ inclusive.
Fenway Health submitted testimony to the chairs of the Ways and Means Committee supporting passage of “An Act relative to parentage to promote children’s security.” The bill would require the use of language in parental rights laws that recognize the rights of LGBTQIA+ families.
Massachusetts House Speaker and the Chair of the House Ways and Means Committee in support of the Healthy Youth Act, which would require school districts that teach sexuality education to use a curriculum that is evidence-based and LGBTQIA+ inclusive.

October, 2020

The Fenway Institute presented at the American Public Health Association Annual Meeting and Expo on “Transgender-related discrimination is associated with substance use and treatment history in a multi-state sample of transgender adults” and “Safe Injection Facilities: What is the evidence?”
The Fenway Institute published “Trump-Pence Administration policies undermine LGBTQ health equity,” a policy brief demonstrating that during its four years in office, the Trump Administration enacted more anti-LGBTQIA+ policies than any previous administration in history. demonstrating that during its four years in office, the Trump Administration enacted more anti-LGBTQIA+ policies than any previous administration in history.
Fenway Health signed a coalition letter to the Massachusetts House Speaker and Senate President and to Conference Committee members organized by Jane Doe Inc. supporting passage of “An Act to reform police standards and shift resources to build a more equitable, fair and just Commonwealth that values Black lives and communities of color.” The bill would prohibit the use of facial recognition technology, place strict limits on qualified immunity, create an Independent Oversight System with strong accountability measures, create a Commission on Structural Racism, and create systems of justice reinvestment and opportunity in communities affected by incarceration.
Fenway Health sent a letter to the state legislature’s Health Equity Task Force urging support for sexual orientation and gender identity data collection in COVID-19 testing.
Fenway Health signed a coalition letter to the state legislature organized by the One Fair Wage coalition urging passage of a full minimum wage for restaurant industry workers because the subminimum wage for tipped workers disincentivizes COVID-19 enforcement.
Fenway Health signed a letter to the Governor organized by the Massachusetts Law Reform Institute in support of allocating $5 million from the IT bond bill to permit health care consumers to apply for SNAP benefits at the same time as they apply for or renew their MassHealth or Medicare Savings Program coverage.

November, 2020

Fenway Health sent a letter to state representatives Sarah Peake and Liz Malia requesting support for a budget amendment to support the LGBTQIA+ Aging Project and to require LGBTQIA+ competency training in elder services.
Fenway Health sent a letter to state representatives Liz Malia, Denise Garlik, and Aaron Michlewitz requesting support for Youth HIV Prevention Access, which would permit minors to access pre-exposure prophylaxis, which reduces transmission of HIV.

December, 2020

The Fenway Institute participated in a briefing on HIV and aging for the Congressional HIV Caucus and Congressional LGBTQ+ Caucus that was organized by Services and Advocacy for GLBT Elders HIV and Aging Policy Action Coalition.
The Fenway Institute participated in a panel discussion organized by MassEquality titled “Marching Together Towards Equality: The Other Epidemic: Ending HIV Stigma & Transmission” for the Canadian Consulate, Quebec Office in Boston.
Fenway submitted public comment to U.S. Department of Health and Human Services in opposition to the proposed rule, “Securing Updated and Necessary Statutory Evaluations Timely” which would “retroactively impose an expiration provision on most HHS regulations, and establish ‘assessment’ and ‘review’ procedures to determine which, if any, regulations should be retained or revised.” Fenway explained that the proposed rule “would undermine Medicaid, Medicare, and the health insurance marketplaces, as well as other core functions of government, such as the critically important health and safety work of the Food and Drug Administration and the Centers for Disease Control and Prevention.” Fenway also noted that the rule was “totally unnecessary for these programs’ proper administration.”
Fenway submitted public comment to the U.S. Department of Health and Human Services; Office of Infectious Disease and HIV/AIDS Policy; Office of the Assistant Secretary for Health on the draft HIV National Strategic Plan released on World AIDS Day, 2020. Fenway wrote to request that “significantly” more attention be paid to the needs of older people living with AIDS and long-term survivors noting that half of people living with AIDS in the U.S. are over 50 years old and “experience multiple comorbidities and increased prevalence of geriatric syndromes such as falls, frailty, and polypharmacy.”
Fenway sent a letter to Dr. Levine and Association of State and Territorial Health Officers encouraging them to “incorporate attention to LGBTQI populations into your COVID-19 vaccine health equity strategies, and to collect and report sexual orientation and gender identity (SOGI) plus intersex data in novel coronavirus testing, COVID-19 care outcomes, and vaccine uptake.” Fenway noted that it is “vital that governments and public health experts have a clear picture of the disparate risks and impacts of the novel coronavirus on LGBTQI people to inform public health efforts.”
Fenway joined a coalition of LGBTQI+ health organizations urging the Advisory Committee on Immunization to “incorporate attention to LGBTQI populations into your COVID-19 vaccine health equity strategies, and to collect and report sexual orientation and gender identity (SOGI) plus intersex data in novel coronavirus testing, COVID-19 care outcomes, and vaccine uptake.” Fenway noted that it is “vital that governments and public health experts have a clear picture of the disparate risks and impacts of the novel coronavirus on LGBTQI people to inform public health efforts.”
The Fenway Institute published “LGBT AGING 2025: Strategies for Achieving a Healthy and Thriving LGBT Older Adult Community in Massachusetts,” a status report on older LGBTQIA+ adults in Massachusetts. The report found that older LGBTQ adults in the Commonwealth report being diagnosed with depression at twice the rate of their straight, cisgender peers, and are twice as likely to fall and be injured in a fall over the past year. It also finds that while older LGBTQ adults are more likely to hold a college degree, they are more likely to report having had difficulty paying for housing or food over the past year. LGBTQ older adults living in rural areas of the state expressed concern about the lack of options for LGBTQ-affirming health care, as well as their on-going experiences with strong anti-LGBTQ prejudice and harassment in public settings and senior housing.
Fenway Health submitted testimony to the Governor and the Commonwealth’s Secretary of Administration and Finance urging support for co-pay assistance in the FY21 state budget.
Fenway Health submitted testimony to the Governor and the MBTA’s Fiscal and Management Control Board opposing budget cuts to the MBTA that result in fewer runs of the 55 bus which is utilized by Fenway Health’s patients and clients to attend appointments.
Fenway Health signed a coalition letter to the Massachusetts Division of Insurance organized by the Center for Health Law and Policy Innovation requiring coverage for all peripheral medical costs related to pre-exposure prophylaxis such as laboratory tests.

January, 2021

The Fenway Institute sent a letter to Massachusetts state legislators appointed to the COVID-19 Health Equity Task Force urging them to support the recommendations of the Health Equity Task Force to collect and report sexual orientation and gender identity data for COVID-19 testing and vaccinations.
Fenway Health sent a letter to Massachusetts state legislators appointed to the COVID-19 Health Equity Task Force urging them to file legislation adopting the recommendations of the Health Equity Task Force to collect and report sexual orientation and gender identity data for COVID-19 testing and vaccinations.

February, 2021

Fenway Health sent a letter to House Speaker Nancy Pelosi and Senate Majority Leader Chuck Schumer urging passage of the Equality Act, which would prohibit discrimination on the basis of sexual orientation and/or gender identity in employment, housing, and public accommodations.
Fenway Health sent a letter to Senator Patty Murray, Chairwoman, and to Senator Richard Burr, Ranking Member, of the Committee on Health, Education, Labor and Pensions urging them to confirm the appointment of Pennsylvania Secretary of Health, Dr. Rachel Levine, to serve as Assistant Secretary for Health.
The Fenway Institute submitted testimony to the COVID-19 Health Equity Task Force urging them to file legislation adopting the recommendations of the Health Equity Task Force to collect and report sexual orientation and gender identity data for COVID-19 testing and vaccinations.
In partnership with AIDS United, Callen-Lorde Community Health Center, GLMA: Health, Professionals Advancing LGBTQ Equality, Howard Brown Health, interACT: Advocates for Intersex Youth, Lyon-Martin Health Services, National Black Justice Coalition, National Center for Lesbian Rights, National Center for Transgender Equality, National LGBT Cancer Network, National LGBTQ Task Force, SAGE, Transgender Law Center, Transgender Legal Defense and Education Fund, and Whitman-Walker Institute, Fenway Health released “Next Steps for Building Better LGBTQI Health,” a policy brief outlining immediate steps for the Biden-Harris Administration to take in public health policy to regain lost ground during the previous presidential administration and lay a foundation for the future.

March, 2021

Fenway Health signed a coalition letter to MassHealth organized by the Association for Community Health Improvement led by the Massachusetts Public Health Association supporting changes to the state’s 1115 Demonstration Waiver from the U.S. Centers for Medicaid and Medicare. The proposed changes would support data collection for racially equitable outcomes, support data collection of sexual orientation and gender identity data, coordinate service delivery and data sharing across state agencies, improve maternal health outcomes, improve outcomes for justice-involved individuals, and support community health workers.

April, 2021

The Fenway Institute submitted public comment to the Office of the National Coordinator for Health Information Technology, Office of the Secretary, United States Department of Health and Human Services urging that the patient demographics requirements in electronic health records be expanded to include sexual orientation, gender identity, intersex status, name used, and pronouns.
Fenway Health sent a letter to leadership in the Texas state legislature urging them to oppose anti-transgender legislation.

May, 2021

Fenway Health submitted testimony to the Massachusetts Joint Committee on Public Health in support of support support of legislation that would permit minors to access pre-exposure prophylaxis, which reduces transmission of HIV.
Fenway Health submitted testimony to the Massachusetts Joint Committee on Education in support of the Healthy Youth Act, which would require school districts that teach sexuality education to use a curriculum that is evidence-based and LGBTQIA+ inclusive.

2021 EVENTS

Click a logo to learn more.

Fenway@50 Virtual Gala

Our Fenway@50 virtual gala, celebrating the 50th year of Fenway Health, was held April 28, 2021. Due to the COVID-19 pandemic, we moved our signature events online for a very special evening celebrating our LGBTQIA+ community.

The evening was hosted by the fabulous Nina West of RuPaul’s Drag Race fame. It included a look back at some milestones from our first 50 years of community care, remarks from public health hero Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases, and musical entertainment from Mel Fine, Neo Gcabo, and Fenway’s own FCHords a cappella group.

Over 560 people logged in to join us for this special community gathering. Together, we raised over $350,000 in donations and auction sales to support the life-saving services and programs at Fenway Health!

We would like to extend special gratitude to our sparkling host, Nina West and to Dr. Fauci for his meaningful remarks. We’d also like to thank Neo Gcabo, Mel Fine, and the FCHords for uplifting us with their voices, and our celebrity guests Roxane Gay and Big Freedia for their messages of encouragement. Thank you to our Sponsors, as always, for supporting Fenway in practicing community care.

During the event, we featured videos that highlighted Fenway’s work in research, trans health care, and youth services, as well as a special Fenway@50 timeline. You can watch and learn more below:

Fenway Health’s First 50 Years

Research at The Fenway Institute: HIV History and COVID-19 Vaccines

Trans Health at Fenway Health

Youth Services at Fenway Health

Harbor to the Bay

Harbor to the Bay is a charity bike ride from Boston to Provincetown that donates 100% of money raised by riders and crew to support HIV/AIDS programs and services at four area agencies, including Fenway Health.

The Harbor to the Bay ride is made possible each year because a core group of dedicated individuals, under the leadership of Harbor to the Bay President and Director Jim Morgrage, volunteer their time and energy to make it happen. So far, Harbor to the Bay has raised over $6 million, with every penny distributed to its beneficiaries. Few volunteer-driven fundraisers can claim such an impressive track record.

The 18th Harbor to the Bay took place on September 26, 2020. Due to COVID-19 restrictions, this year’s event was a little different. H2B Your Way was held virtually, with “riders” choosing their own routes and ways to participate, including biking, running, walking, and swimming.

In 2020, Fenway Health was represented by 34 riders and AIDS Action was represented by 11 riders. All the money they raised will ensure that Fenway and AIDS Action can provide care and services to every HIV-positive person who comes through our doors, regardless of their ability to pay. Altogether, the 2020 Harbor to the Bay Ride raised $85,105 for Fenway Health and $26,187 for AIDS Action.

We want to extend a huge thank you to all our incredible riders and donors for making this ride such a success.

18 Rides

45 Riders

$111,292 Raised

These lists reflect donors and volunteers for fiscal year 2021, July 1, 2020 – June 30, 2021.

AIDS Action Riders

Kaan Apaydin

Peggy Burns

Michelle Buse

David Do

Andi Genser

Katherine Hartley

Colin Patrick Hildenbrand

Morgan Hughes

Justin T. Isaac

Mohammad Jalali

Robb W. Johnson

MA Ladd

Raul G. Medina

Carrie Richgels

Carl M. Sciortino, Jr., MPA

Jennifer Swanson

Eli Wasserman

Brian Weiner

John C. Welch, DNP

Fenway Health Riders

Amanda Annis

Arunabh Arora

Clint Attebery

Thomas Barth

Richard Blank

Edward Boyer

Doc Cesmebasi

Ross Cooper

Ken DeBlois

Roberta K. Eriksen

Philip Finch

Timothy J. Fitzgerald

Niamh C. Foley

Matthew Gibson

Monique Girard

Warren Green

Eric Greenberg

Catherine A. Grossi

Nicholas Hoover

Clarice Johnson

Ian W. Johnson

Ben Kudler

Barron Lambert

Cei Lambert

Ken A. Levine

Nachiket Londhe

Aaron Malgeri

Kristen McIntire

Matthew J. McNeff

Malinda J. McPherson

Roland Merchant

Laura O’Neil

Emmett Patton

Jeff D. Pike

Jane D. Powers, MSW, LICSW

Brian Powrie

Valentina Rosa

David J. Russo, Jr.

Robert Santiago

Melissa Savage

Abdel Sepulveda

Erina Spiegelman

Julia Spiegelman

Jeffrey Sulloway

Guru Swamy

Mark Vogel

Parker Wellington III

Donnie Worth

Zeming Yang

Michael Yeh

AIDS Walk & Run

The 35th Annual AIDS Walk & Run was held virtually on October 18, 2020 do to the COVID-19 pandemic. While we missed being able to take it to the streets in person, we had a tremendous turnout for the online event (you can access the recording of the Walk here), which included incredible guest speakers such as Fenway Health’s CEO Ellen LaPointe, Boston Mayor Marty Walsh, and Congresswoman Ayanna Pressley—who was the 2020 Bette Byrnes Award recipient (click here to watch her acceptance).

For the FY21 Walk/Run, we invited all participants to walk or run 3.1 miles right in their own neighborhoods. We were joined by 343 amazing and dedicated supporters who helped raise $220,000 to support the vital work of Fenway Health and AIDS Action to fight HIV and help those living with or at risk of contracting this horrible disease.

These fundraising efforts would not be possible without both corporate and individual participants. Leading fundraising teams like Dunkin’ Brands’ Team INspire, not only raised $13,794, but also served as our Official Breakfast Sponsor and donated gift cards to each of our participants. Other top fundraising teams included The Ragon Institute of MGH, MIT, and Harvard ($56,424), John’s Team ($28,913), Vertex Pharmaceuticals ($20,030), and the Fenway Family ($8,047). The top five individual fundraisers in 2020 were Bruce Walker, Inez Folsom, Joshua Boger, Amy Boger, and Jonathan Urbach.

343 Supporters

$220,000 Raised

AIDS Walk Team Fundraising

GOLD TEAMS

The Ragon Institute

John’s Team

Vertex Pharmaceuticals

INspire Dunkin’ Brands

Fenway Family

SILVER TEAMS

Alnylam

North Shore Walks for Verny

Schreiberian Running Club

BRONZE TEAMS

Beth Israel Deaconess Medical Center

FY21 Fundraisers over $500

Bill Adams

Saket Agarwal

Helene S. Bednarsh

Joshua S. Boger, PhD and Amy Schafer Boger, MD

Christine Bricault

Francisco Castro and
Richard D. McCarthy

Ross Condit

Linda L. Cotter-Cranston and Scott W. Cranston

Kimberly P. Cummings

Brian Derrick

Amby Drake

Jonathan Farley

Niamh C. Foley

Inez D. Folsom

David S. Fontaine

Lauren J. Gabovitch and
Bill Gabovitch

Sharon Glasser

Nancy L. Goldberg

Gordon M. Gottlieb

Morgan Grenier

Jim Haber

Bryan Horgan

Pete Jensen

Julie E. Kaufmann

Peter Konrad and
Shaun Watson

Kristen J. Lascoe

Helder Lemos

Brian Liberge

Eileen MacDougall and
Brian T. MacDougall

Jonathan A. McIntyre

Chad Michael and David Michael

Margret O. Nelson and Andrew W. Nelson

Allison P. Newman

Patricia A. Nichols-Cordero and Andrew P. Cordero

Shaun Noone

Isabella O’Connell

Kathryn Price and Tim Price

Gregory Rayo

Louise B. Rice and Tess Ewing

Arnold E. Sapenter and Joseph C. Reed, PhD

Ann E. Schlesinger

Warren M. Schur

Dawnmarie Simpson

William C. Smaha

Annie Smith

Jennifer Tran

Rita T. Tries and
James H. Tries

Jonathan M. Urbach

Joseph D. Vogel

Bruce D. Walker and
Alice M. Cort

Taste of the South End

While the 2020 Taste of the South End was held virtually, we had an incredible event that was supported by over 200 people who purchased tickets and tuned in to help raise over $82,000 to support Fenway Health and the communities we serve.

While it would have been delicious to gnosh together in person at the Cyclorama, it was delightful to celebrate the “Taste” community online. The event program featured a thank you to our donors from our host committee co-chairs Michelle Losasso and Donna Venegas, CEO Ellen LaPointe joined us to introduce herself to the Taste of the South End community, and The Sisters of Perpetual Indulgence spiced up the evening and added some off-color cheer.

It wouldn’t be a Taste of the South End unless we were joined by some of Boston’s finest chefs and restaurants. Joanne Chang of Flour and Myers and Chang was on hand, along with several other celebrity chefs including Chef Michael Lombardi of SRV, Chef Jimmy Liang of Fuji, Chef Alima of Haley House, and Chef Douglass Williams of MIDA who each presented cooking tutorials of some of their favorite dishes. Last, but certainly not least, while we couldn’t be together to share a meal in-person, several of our Taste restaurant partners provided exclusive one-night-only discounts to help celebrate the evening.

Please be on the lookout for more information regarding Fenway’s 2022’s new events!

220 Supporters

$82,000 Raised

Host Committee Co-Chairs

Michelle Losasso

Donna Venegas

Gold & Silver Patrons

Darrell Smith

Participating Restaurants

Anoush’ella

Aquitaine

B&G Oysters

Banyan Bar + Refuge

Bar Lyon

Bar Mezzana

Barcelona South End

The Beehive

Blackbird Donuts

Black Lamb

Boston Chops South End

Brownstone

Burro Bar

The Butcher Shop

Cinquecento

Cosmica

El Centro

Fazenda Coffee Roasters

Five Horses South

Flour Bakery + Café

FoMu

Formaggio Kitchen South End

Frenchie

Fuji at Ink Block

The Gallows

Gaslight Brasserie du Coin

Haley House Bakery Café

Masa Latin Kitchen + Tequila Bar

Mela Modern Indian Cuisine

Metropolis

MIDA

Mistral

Myers+Chang

No Relation

Orinoco

Picco

Sally’s Sandwiches

Shore Leave

South End Buttery

SRV

SUPPORTERS

Board of Directors (2020-2021)

Jonathan Matsui, PhD
CHAIR

Diane M. Tucker
VICE CHAIR

Scott Walker, CFA
TREASURER

Trevor Z. Boylston
CLERK

Benjamin Davis, MD

David J. Davis, RN

Harold du Four-Anderson, M.Ed, LADC I

Roxane Gardiner, MD, MPH, MSHPEd, DSc

Colin Gibbons, MHA

Guadalupe Hayes-Mota, MBA, MS, MPP

Mikhaela Houston

Jennifer L. Jones

Michael A. Kramer, DDS, DMSc

Seth Levenson

Lisa L. Paine, CNM, DrPH

Amy Rasimas, MBA

Bianca Robinson, MBA

Betsy Smith, PsyD

Vincent C. Smith, MD, MPH

Joblin C. Younger, Esq.

Board of Directors (2021-2022)

Jonathan Matsui, PhD
CHAIR

Diane M. Tucker
VICE CHAIR

Scott Walker, CFA
TREASURER

Joblin C. Younger, Esq.
CLERK

Trevor Z. Boylston

Robert Chambers

Jennifer Chrisler

Benjamin Davis, MD

David J. Davis, RN

Harold du Four-Anderson, M.Ed, LADC I

Roxane Gardner MD, MPH, MSHPEd, DSc

Colin Gibbons, MHA

Lillian Gonzalez, CPA, MST

Guadalupe Hayes-Mota, MBA, MS, MPP

Mikhaela Houston

Jennifer L. Jones

Michael Kramer, DDS, DMSc

Amy Rasimas, MBA

Betsy Smith, Psy.D

Vincent C. Smith, MD, MPH

Board of Visitors

The Board of Visitors’ mission is to heighten Fenway’s visibility and provide additional expertise and experience to support the organization and its work. Fenway’s Board of Visitors members are interested and influential members of the community, patients, donors and friends. Ryan Gosser was the Chair of Fenway’s Board of Visitors.

Godwin C. Aduba

John N. Affuso

Karen Akunowicz

Jacob Andrus

Mikki Ansin

Christopher R. Arrington

Robin A. Atlas, MD

Steven Auerbach

Ashley L. N. Banfield

John H. Basile

Jeffrey Blackwell

Mara Blesoff

Casey Brown

David W. Brown

Taylor Brown

Bryan Bryson

Catherine D. Burgess

James C. Buttrick

Leah C. Camhi

Richard B. Carey

Alexandra Chandler

Stewart B. Clifford, Jr.

Harry R. Collings

Gillian Comito

John M. Costello

Deborah A. Daccord, Esq.

Gary K. Daffin

David M. Datz, Esq.

Katelyn Dolan, PT, DPT

Jeffrey P. Dugan

Steven P. Dyer

DeeDee Edmondson

Meryl Epstein

Thomas P. Evans

Daniel E. Ferrell

Philip Finch

Timothy J. Fitzgerald

Arlene Fortunato

Steven F. Fossella

Isabella M. Gambill

Ryan Gosser*

A.J. Goulding

Jack Gronau

John A. Haas

Cyrus Hamer

Eugenia Handler

Cynthia Harmon

Taylor S. Harris

Charlie R. Hindmarsh

Andy Huang, CPA

Justin T. Isaac

Maxine Jackson

John B. Koss, Esq.

Michael Kozuch

Matthew D. LaBrie

Mary Landrigan-Ossar

Ted T. Lee

Stephanie Letzler

Bruce A. Lewis

Rhonda J. Linde

Jonathan S. Litt, MD

Michael Lowenthal

Paul E. Lynch, MD

Matthew W. McGuirk

Michael E. McHugh

Mary Beth McInerney

Raul Medina

Leif Mitchell

Lindsey L. Noecker

Bisola O. Ojikutu, MD, MPH

Rev. Fr. Alex Oneto

Dale Orlando**

Liz Page

Jennifer Petter

Jay Philomena

Elizabeth Pilgrim

John R. Pitfield, Esq.

Bryan C. Pridgen

Brian Ramos

Angela L. Rappoli

Ms. Gena Ricciardi

Louise Rice

Glenn A. Rigoff

Alessandra R. Robinson

Carol A. Roby

Jonathan S. Rotenberg

Arnold E. Sapenter

Regina Savageau

Sarah Schochet

James R. Seligman, DMD

Douglas W. Spencer

Richard Spencer

Caleb Paul Stewart

Dr. Adam M. Tobias

Paul B. Toomey

Teresa Trammell

William M. Webster

John C. Welch

Matthew Wilder

Claire B. Willis, LICSW

Michael T. Wong

Brady Wyrtzen

Cristina Yordan

Richard J. Yurko

David Zimmerman

Stephen H. Zinner, MD

*Chair
**Deceased

Corporations and Foundations

The following companies and foundations generously support Fenway Health’s mission. Whether through their event sponsorship, targeted support of specific programs or services, or general support, Fenway is truly grateful to have these partners in support of the care we provide.

$250,000+

Beth Israel Lahey Health

Massachusetts eHealth Collaborative

$50,000-$249,000

The Boston Foundation

Commonwealth Care Alliance

Direct Relief

Eugene M. Lang Foundation

Fidelity Foundation

Gilead Sciences, Inc.

Harbor To The Bay Inc.

Income Research + Management Charitable Fund

Liberty Mutual Foundation

Massachusetts League of Community Health Centers

RIZE Massachusetts

$25,000-$49,999

Broadway Cares, Inc/Equity Fights AIDS

Takeda Pharmaceuticals

Tikkun Olam Foundation, Inc.

$10,000-$24,999

Anonymous

American Tower Corp.

Biogen Idec Foundation

Blue Cross Blue Shield of Massachusetts Foundation

Boston University

Consumer Medical

Eastern Bank Foundation

Elizabeth Taylor Foundation

The Hamilton Company Charitable Foundation

Henry J. Kaiser Family Foundation

Janssen Products, LP

Karyopharm Therapeutics, Inc.

Macy’s Foundation

Moderna

Project Bread

PwC LLP

Santander Bank

The Bernard and Anne Spitzer Charitable Trust

Wistia

$5,000-$9,999

Alexion Pharmaceuticals, Inc.

Alnylam Pharmaceuticals

Apple

The Susan A. and Donald P. Babson Charitable Foundation

The Bennett Family Foundation

Berkshire Bank Foundation

Boston IVF

Cambridge Community Foundation

Cambridge Savings Bank

Eaton Vance Management

Joy in Childhood Foundation

The Kessler Family Foundation

KPMG

Locke Lord LLP

People’s United Community Foundation of Eastern MA, Inc.

Robert Lloyd Corkin Charitable Foundation

Rockland Trust – Blue Hills Charitable Foundation

Ropes & Gray LLP

TD Charitable Foundation

Tufts Health Plan

Venegas and Company LLC

Vertex Pharmaceuticals, Inc.

Walgreen Co

Woolley-Clifford Foundation

$2,500-$4,999

AAFCPAs

athenahealth

BNY Mellon

Boston Evening Clinic Foundation

Brown Brothers Harriman

CareAcademy

Cityside Subaru

Deloitte & Touche USA LLP

Dowling & O’Neil Insurance Agency

Forest Foundation

Janssen Therapeutics

Law Office of Joblin C. Younger, P.C.

MassMutual Financial Group

The MENTOR Network Charitable Foundation

MLS Property Information Network, Inc.

New England Homecrafters, Inc.

Performance Northeast Services, LLC

Quest Diagnostics

Sacajawea Charitable Foundation

Tufts University

Wellington Management Company, LLP

$1,000-$2,499

Amazon Smile

Art 4 Health

The Barrington Foundation, Inc.

Bessemer Trust

Citizens Bank

Consulate of Canada – Boston

Cummings Properties, LLC

First Church Somerville UCC

Friends Meeting at Cambridge

Hae Ahm (Sea Rock) Foundation

John Hancock Financial Services

MFS Investment Management

Premier Martial Arts – Stoughton

The Royal Commonwealth Society Inc.

Sappi North America

The Society of Saint John the Evangelist

Tufts Health Plan Foundation

UMass Overwatch

United Way of Massachusetts Bay & Merrimack Valley

$500-$999

Ameriprise Financial

Combined Jewish Philanthropies

Entegris Inc.

Flour Bakery & Cafe

Gartner, Inc.

GLBTQ Legal Advocates & Defenders

JSP Family Foundation

LGBT Elders of Color

LitmanGerson Associates, LLP

Loomis, Sayles & Company, LP

Mennonite Congregation of Boston

Microsoft Giving Campaign

Nuance Communications

PayPal Gives

Planned Parenthood League of Massachusetts, Inc.

QurAlis Corporation

RepTrak

Second Street Associates, LLC

Our Generous Donors

The following lists reflect donations made to Fenway Health and AIDS Action during fiscal year 2020, July 1, 2020 through June 30, 2021.

$100,000+

Mary C. Jigarjian and George Jigarjian

$25,000-99,999

John M. DeCiccio

Shaun P. McMahon

J. Scott Walker

$10,000-24,999

Godwin C. Aduba and Tim Byrne

Steven Auerbach and Mark Scofield

Joshua S. Boger, PhD and Amy Schafer Boger, MD

Raphael Jaimes-Branger and Eliot T. Wright

Betty I. Morningstar and Jeanette Kruger

Anne M. Peterson and Mark A. Peterson

Kevin P. Wulff

$5,000-9,999

Anonymous (2)

Gregory D. Ansin

Ashley Banfield and Emily Drahzal

James C. Buttrick

James E. Canales and James C. McCann, MD

Pamela D. Choney and Jeffrey A. Choney

Stewart B. Clifford, Jr.

Steven D. Corkin and Dan Maddalena

John R. Ehrenfeld and Ruth R. Budd

Nicholas Everage, PhD

A.J. Goulding and Jason Huang

Lori J. Griffiths and Family

Matt Gromada and Javier Lopez-Molina

Patrick C. Guerriero

Paul Hempel

Joanne Herman and Terry Fallon

Thomas M. Kennedy

Matthias D. Maguire

Mary Beth McInerney and Susan Barclay

Jeffrey B. Meaney

Brian T. Mitchell

Jeffrey H. Munger and Robert T. Whitman

Daniel S. Newton and Christopher L. Flynn

Ernest J. Pusateri

Louise B. Rice and Tess Ewing

Sarah Schochet and Darrah March

Andrew Sigel

Kathleen A. Tucker

Ann M. S. Wiencek and Paul R. Wiencek

Eddie Zaidner, MD

Yijie Zhang, PhD

$2,500-4,999

Karina Bercan

Joseph Castellana, PhD and
James R. Seligman, DMD

Brian P. Cooper, PhD and
Margueritte S. Murphy, PhD

Marco A. DeThomasis

Stephen C. Harrison and Tomas Kirchhausen

Kenneth F. Hirschkind

Ellen Hurvitz and Barry Strasnick

Lorraine Jones and Elizabeth Halstead

Peter F. Jones and Wayne G. Gaffield

Kenneth W. Kendrick, Jr.

William W. Kimball

G.P. Paul Kowal

Mary Landrigan-Ossar, MD, PhD and Jacob Ossar

Jillian Levine and Sherry Cheuk

Mark H. Libenson, MD and Lisa M. Muto, PhD

Raul G. Medina and Bradley Ursillo

Renee L. Miltz

Michael J. Piore and Rodney L. Yoder

Brian Price, MD and Paul D. Anagnostos

Joseph T. Realmuto, Jr.

Michael L. Reney and Alexander Cruz

Paul and Carol Rose

Craig M. Sato and Joseph J. Takarewski

Charles Steenburg

Caleb Paul Stewart

John C. Welch, DNP

John F. Winterle, DMD

Joblin C. Younger, Esq.

Jose R. Zorola

$1,000-2,499

Anonymous (3)

John N. Affuso

Ceceilia Allwein

Gary Bailey, MSW

The Barrington Foundation

Michael J. Barry, MD and Jean W. Barry

John H. Basile

R. David Beck and Gregory R. Van Boven

Kathleen R. Beckman and Theodore Postol

Steven H. Berez

James M. Bonanno, MD and John J. Cormier

Mohan D. Boodram and Robert F. Morris

Michael and Jennifer Borislow

Armene A. Boyajian

Trevor Z. Boylston

William H. Brack and Jessica A. Ladd

The Honorable David J. Breen and
Michael R. Harrington

Margot H. Brickelmaier

William B. Brockman and Lucy E. Hadden

Randy Broomhall-Dillard, PhD

Graham T. Brown

Robert L. Buckwalter

Joseph M. Cacciola and
Thomas G. J. Trykowski, AIA

Dr. Christopher L Campion & Jason M Vellen

Richard B. Carey

Robert M. Caro

Stewart and Patricia Chapin

T. Coletti

Dennis E. Condon and Robert J. Cummings

Lance W. Connolly and Kelly Connolly

Jeff A. Conrad

Zachary Coseglia and Benjamin Soisson

Deborah A. Daccord, Esq.

David J. Davis and Tracy Thompson

Frederick J. Doherty

Harold du Four-Anderson

Peter J. Epstein, Esq.

Thomas P. Evans

Raymond Faulkner and Carlos M. Terra

Valerie and Jacqueline Fein-Zachary

Dena B. Feldstein and Edward Brody

Philip Finch and William Halpin

Lindsey Flanagan

Theodore L. Fleming and Kathryn B. Fleming

Arlene Fortunato and Darcy Pfeifer

Domenic Gaeta

Janet and Andrew Gainer-Dewar

Clifton A. Gaskill

Robert L. Geary

David A. Georgantas

Tracy Germann

Cynthia M. Goncalves and Shane A. Depina

Alex Gonzalez, MD, MPH

Anne K. Goodman

Mia Gore and Abraham Gore

Mary L. Gray

Don and Mary Green

Anthony Grillo

Edward M. Gromada and
Madeleine T. Gromada

Mark L. Guenard

Ross Harpestad

Taylor S. Harris

Timothy B. Harwood

Guadalupe Hayes-Mota

Deborah Heller, PhD and Ann Sanders

Stephen J. Hendrickson and David McCord

Timothy T. Hilton

John S. Hoag

Peter E. Hornstra

Derek A. Howe and Brian S. Galloway

Andy Huang

Matthew Jemison

Wendy E. John

Ian W. Johnson

Jennifer L. Jones

Catherine Kapadia

Todd A. Katzman and Marc Lacasse

Richard Kovalcik

Jill Kowal

Ellen LaPointe and Jen Cross

Ted T. LeeDiane K. Lincoln

Derek R. Lisinski

Jonathan S. Litt, MD

Clarence R. Lyons

Lucy Mack

Ryan MacLean

Edmond R. Macri

Thomas J. Martorelli

Christine Matsui and Jerold Matsui

Jonathan I. Matsui, PhD and R. Bryan Smith

Kenneth H. Mayer, MD

Michael E. McHugh

Robbie J. Meitler

Daniel A. Michaud, MPA and Brice Booker

Neal Minahan and Eric Archibald

MaryAnn Moskofides

Jess Muskin-Pierret

John E. Paap and Mary L. Paap

Liz Page and Marianne Stravinskas

Lisa Paine, CNM, DrPH and Linda Daniels, PsyD

Samuel Pang, MD and Andrew Pang

Stephen P. Pentek

Benjamin D. Perkins and David W. Brown

Brian K. Perry and Kevin Crawford

Kevin Peterson

Jennifer and Catherine Petter

Michael Pickard

John R. Pitfield, Esq. and Paul E. Lynch, MD

Tina M. Pittore

David J. Poorvu and Nancy Poorvu

Jenny Potter, MD and Joyce L. Collier

Jane D. Powers, MSW, LICSW and
Margaret M. Hayes

Michael E. Profenno

Rick Redmond

Joey Riddle

Lewis Rieley and Bryan Barbieri

Glenn A. Rigoff

Louis F. Risoli and Charles B. Fisk

Bianca Robinson, MBA

William B. Rubenstein

Arnold E. Sapenter and Joseph C. Reed, PhD

Dorothy A. Savarese

Glenn A. Seberg

Ellen Semonoff

Diane Sidorowicz and Lourdes Rodriguez

Michael Skrip and James M. Brown

Gary R. Sloper

Cornelia E. Smith and Berit Pratt

Vincent C. Smith, MD, MPH

Naomi Sobel and Becky Silverstein

Douglas Spencer

Sally A. Stalker

Blaze A. Stancampiano

Dan Sugalski

Joseph Sullivan III and Jay Qu

Christopher Sutherland and Steve Quezada

James M. Sweeney

Deb G. Taft and Terri L. Rutter

Peter Tenggren and Warren Mitchell

Hal Tepfer and Stacie L. Simon

Vic Terawskyj

Mark E. Toney and Daniel J. Hartigan

Diane M. Tucker

Leigh J. Tucker and Stephen R. Mehrtens

Kevin J. Tully

Dorothy A. Van Ryzin

Joseph C. Veneto

Lenore Von Krusenstiern

Thomas P. Webber and Keith J. MacDonald

Becky Weidenbruch and John Weidenbruch

Martha L. Wengert and Laura E. Dorfman

Kim Williams and Trevor Miller

John P. Wolfarth and Kevin W. Powers

Michael T. Wong, MD

Stephen H. Zinner, MD

Michael F. Zito

Robert Zverina and Kathy A. Spiegelman

$500-999

Anonymous (4)

Jonathan B. Aibel and Julie I. Rohwein

Jazzmine Arbuthnot

Jesse Baerkahn

Julie E. Bailit and Michael H. Bailit

Karl A. Basile and Charles T. Oden

Kenneth J. Bazydola and Sarah M. Bazydola

Kaytie Beasley

Emily Beinecke

Jerry M. Bernhard

Ilouise Bradford

Carol J. Bresler and Carolyn A. Billinghurst

Carson Burrington

Patricia J. Caldwell and Richard L. Connolly

Leah C. Camhi and Amy A. Pitter

Juliet Carey, MPH and Barbara Parton

Alexander G. Carlock

Roger M. Carter

Martha J. Cutting and Frank J. Cutting

André and Marilyn Danesh

Norman R. Daoust

John D. Degnan

Cecelia A. DeMarco and Anne M. Campbell

Katelyn Dolan, PT, DPT

Peter J. Dominski

Karyn Donahue

Mark J. Duffy

Steven P. Dyer

George P. Edmonds III and Athena Edmonds

Leif W. Ellisen, MD, PhD

John W. Erickson and Michael E. Field

Paul W. Ernest and Camille G. Ernest

Kimberly T. Erwin

Gary Fallas

MK Foley

Niamh C. Foley

Jason Fox-Reardon

David Ganak and James Sargent

Michael J. Gillespie and Paul Braswell

John W. Gintell and Robert S. Coren

Frank V. Graziano and Jennifer A. Graziano

Lisbeth J. Hall

Megan Hall and Honor MacNaughton

Matthew Hamilton

Sarah E. A. Hanselman and Eric G. Hanselman

Christina Heinrich

Donald Heinrich

Clinton A. Heitman

Richard Higger

Anita L. Huggins and Norman W. Huggins

Gilbert L. Huppert

Alan H. Ingram, Jr.

Fern L. Johnson and Marlene G. Fine

Elizabeth Kass, MD

Jeffrey A. Kramer

Michael A. Kramer, DDS, DMSc

David A. Kronman

Ronald V. Lacro and Jon P. Schum

Richard Lerner

Jonathan Li

Daniel A. Lowen

Eva Lundsager

William T. Lynch and Ingrid G. Larson

Michael Malafronte

Shibin Mathew

Zachary D. McCabe

Theresa M. McLaughlin

Malinda J. McPherson

Michael Meidinger

Matthew Metivier

Andrew Meyer and Anthony Fallon

Robert F. Monaco

Sarah S. Nielsen and Dana B. Nielsen

Lindsey L. Noecker

John T. O’Keefe and Mark D. Smith

Faith K. Parker and Glenn P. Parker

Hayley Parker

Elizabeth C. Parsons

Christopher Perrotti and Taice Perrotti

Monika Pichler

Wayne B. Powell

Moose Price

The Racemaker Charitable Fund at The Chicago Community Foundation

Abram Recht and Martha Recht

Valentina Rosa

Jon Z. Rosbrook

Michael Rotenberg and Karen S. Rotenberg

Catherine N. Ryan

Steven Salerno and Adrianne Seiler

Fillip Saraiva

Defne Sastim

William J. Sawyer and Pamela P. Sawyer

Carole Schlessinger

Lyn Shamban

Zachary Shearn

Luther W. Smith

Mary G. Smith and Simone Reagor

Pamela A. Smith and Steven E. Thomas

Ryan Smith and Dante Ramos

Wendy Stead

David Strichartz and Collenne Strichartz

Anna Tanabe-Robichaud

Fred M. Taylor

Stephen Thrush

Steven J. Tromp

Robin F. Verdier

Corinne Vien

Richard Voos

James C. Wadleigh

Cathy L. Walker

William M. Webster and Jeffrey P. Dugan

Irene M. Weigel and Lynn B. Weigel

Scott R. Wilson

George D. Wright IV

David Wypij and Timothy M. Baum

Haviland Society

The Haviland Society was founded to recognize and to honor Fenway’s most crucial

donors, those who consistently give to the Annual Fund year after year.

Visionaries – Tier 3

10+ years of support

Anonymous (14)

Carole J. Aaron

Michael Achey

Beverly and Nellie Adams

John H. Adams

Eve Adler and Scott Groper

John N. Affuso

Jonathan B. Aibel and Julie I. Rohwein

Michael S. Albert

Larry Albertson

Philip J. Allessio

Kenneth M. Aloisi

Frances Ames and Maureen Dubois

Martin R. Anderson

Amanda Annis and Guillermo Velasco

Gregory D. Ansin

Mikki Ansin

Jonathan S. Appelbaum, MD and William D. Morowski

Tammy L. Arcuri, Esq.

Katharine B. Arnstein

Paul B. Atwood and Rebecca H. Atwood

Paul A. Auerbach and Nancy D. Auerbach

Pierre F. Auger and Jill F. Auger

David N. Aurelio

James Aurelio

Robert P. Babineau

Julie E. Bailit and Michael H. Bailit

Raymond L. Barnes

Joseph P. Barri

The Barrington Foundation

Michael J. Barry, MD and Jean W. Barry

John H. Basile

Iain G. Bason

Bev Bates and Chris Connors

Kenneth J. Bazydola and Sarah M. Bazydola

R. David Beck and Gregory R. Van Boven

Bettina Beckman and Ronald J. Castile

Kathleen R. Beckman and Theodore Postol

Sally Beecher and Harold M. Moren

Peter P. Belobaba

Alan R. Bender

Adrienne R. Benton

Steven H. Berez

Jerry M. Bernhard

Marilyn Bernstein

Alden J. Bianchi and Mary E. Kett

Philip C. Bibb

Leisa D. Binette

Jeffrey Blackwell

Elizabeth M. Blaicher

Arthur R. Blake

Eleanor M. Blakeney

Michael A. Blau and Dianne A. Blau

Nora Bloch

Stephen J. Bobrinitz

Edward S. Boesel

Joshua S. Boger, PhD and Amy Schafer Boger, MD

Carrie Bolster

James M. Bonanno, MD and John J. Cormier

Bruce P. Boni

Mohan D. Boodram and Robert F. Morris

Jennifer T. Borhegyi and George L. Borhegyi

Michael C. Borislow and Jennifer A. Borislow

Debra K. Borkovitz

Jennifer M. Boyle and Christopher Rowley

Trevor Z. Boylston

Billie R. Bozone

William H. Brack and Jessica A. Ladd

Stephen P. Bradley and Edeltraud D. Bradley

Peter J. Brady and Alan Davis

The Honorable David J. Breen and Michael R. Harrington

Gary B. Brenner

Carol J. Bresler and Carolyn A. Billinghurst

Margot H. Brickelmaier

Judith H. Briss

Randy Broomhall-Dillard, PhD

David W. Brown and Benjamin D. Perkins

Kevin Brown

Kristine P. Brown and Scott P. Brown

Kenneth A. Bryant and Diane J. Bryant

Wayne M. Bryant and Maryann Grenier

Robert L. Buckwalter

Richard J. Buirkle

Sherry Burke

Steven and Helen Burns

Susan O. Bush

James C. Buttrick

Paul Buzzell

Joseph M. Cacciola and Thomas G. J. Trykowski, AIA

Sean R. Cahill

Patricia J. Caldwell and Richard L. Connolly

John and Annette Campbell

James E. Canales and James C. McCann, MD

Arthur A. Canter and Gary R. Brissette

Leon Cantor and Jayne E. Cantor

Joseph R. Caputo and James W. Hanosh

R. W. Card

Juliet Carey, MPH and Barbara Parton

Joseph A. Carrese and Michele E. Beaulieu

Barbara J. Carrigg

Kirk and A. Price Carter

Melissa Carter

Roger M. Carter

Roger M. Cassin and Irma M. Schretter

Joseph Castellana, PhD and James R. Seligman, DMD

Michael A. Castellana and Robert Rothery

Kenneth F. Caulfield

Helen T. Chapell

Elyse D. Cherry

Christofer Chiappa

David P. Chicoine

Anne McAdams Chochrek and Joseph Chochrek

Pamela D. Choney and Jeffrey A. Choney

Nina F. Cimini

Anderson Clark, PhD

Dorie Clark

Jessica and Meredith Clemons

Janet A. Clifford

Stewart B. Clifford, Jr.

John Coakley

Laurie H. Cohen

Robert S. Cohen

Joyce L. Collier and Jennifer Potter, MD

Harry R. Collings and Daniel B. Moon

Jane L. Collins

Dennis E. Condon and Robert J. Cummings

Michael and Louise Connelly

Lance W. Connolly and Kelly Connolly

Jeff A. Conrad

Michael G. Conway

Barry B. Corden

Steven D. Corkin and Dan Maddalena

John M. Costello

Peter B. Coughlin

Paul L. Coulombe

Marsha L. Cramer and Michael Cramer

Harold S. Crowley

Teresa H. Crowley and Daniel J. Crowley

Gabrielle M. Cunningham and Carl J. Cunningham

Tom Daccord

Arthur Dahl

Joan C. Dalto and Edward A. Dalto

Lisa Dames and Barry N. Wilensky

André and Marilyn Danesh

Jessica L. Daniels

Norman R. Daoust

Philip R. Daoust

Diane Davidson and William Weidacher

Marc J. Davino

David De Rosier and Esta DeRosier-Markin

Grace E. Deasy

John M. DeCiccio

Emily R. DeMelo

Edward J. DeMers

Donald E. Denniston

William P. DeRosa

David F. DesLauriers and Kevin Durand

Marco A. DeThomasis

Mary L. Dill

Frederick J. Doherty

Peter J. Dominski

Laura E. Dorfman and Martha L. Wengert

Brenda Doyle

Margaret E. Doyle

Mark J. Duffy

Nan Dumas

Frank M. Dunn and Sheila Condon

Michael Duttlinger

Steven P. Dyer

Lee Edelman and Joseph Litvak

George P. Edmonds III and Athena Edmonds

John R. Ehrenfeld and Ruth R. Budd

Andrew Q. Ellingson

Leif W. Ellisen, MD, PhD

Stephen J. Engler and John S. F. Lopes

Leonard A. Epstein and Diane L. Clark-Epstein

Linda F. Epstein

Peter J. Epstein, Esq.

Paul W. Ernest and Camille G. Ernest

Kimberly T. Erwin

Donald H. Eunson

G. Douglas Evans

Thomas P. Evans

Willie Evans

Kyle Y. Faget, Esq.

Brian Falvey

Gail D. Fanning-Grove

Susan E. Faris and Charles Faris

Randal Farrar

Sally Farrell

Michael T. Fatale

Teresa L. Faulisi

Raymond Faulkner and Carlos M. Terra

Valerie and Jacqueline Fein-Zachary

Daniel E. Ferrell and David N. Rogers, Ed.D.

Jared A. Fijalkowski

Bruce W. Finch and Keith A. Reimann

Philip Finch and William Halpin

Renee Finn and Steven Finn

Arthur M. Finstein and Lois A. Finstein

Michael Fiorentino

Timothy J. Fitzgerald

Paul J. Flannery

Frank V. Fleming and Edward M. Fleming

Michael Flier and David Trueblood

J. Kevin Foley and Elaine K. Foley

Niamh C. Foley

Jelena T. Follweiler

Inez D. Folsom

David S. Fontaine

Arlene Fortunato and Darcy Pfeifer

Steven F. Fossella

Susan E. Foster and Bruce Horwitz

Victoria Fowler and Ileen Carrel

Kate Fractal

Paul M. Frascella

Victoria C. Fremont

Sally Friar, DC

Donna A. Friedman

Andrew M. Fullem

Russell Furtado and Charles Smith

Lisa S. Fusaro, MD and Maura Shaughnessy, MD

Philip A. Gambone

Roxane Gardner

Gina M. Gargano

Clifton A. Gaskill

Robert L. Geary

Jerry Gechter and Anne M. Gechter

Michael J. Gettings and Lars Lundgren, MD

Kathy A. Gianino and Alice M. Knowles

Paul B. Gilbert and Patricia C. Romeo-Gilbert

Sterling B. Giles

Robert W. Gill

Michael J. Gillespie and Paul Braswell

Arthur L. Gilman

Barbara E. Gleken

Cindy B. Goldstein and Roger N. Goldstein

Alex Gonzalez, MD, MPH

Andrew Goodman

Anne K. Goodman

Deborah R. Goodman

Robert Goodman

Gordon M. Gottlieb

A.J. Goulding and Jason Huang

Christina Grasso, MPH

Elizabeth W. Gray-Nix

Leona Green

Peter G. Green and Lucy A. Green

Michael and Arlene Greenstein

Robert L. Greenwald

Marcia N. Grey

Stephen A. Griffin

Lori J. Griffiths and Family

Carolyn Grillo and Erin Deadmon

John W. Grindrod and Janice M. Grindrod

Edward M. Gromada and Madeleine T. Gromada

Matt Gromada and Javier Lopez-Molina

Mark L. Guenard

Robert M. Guerin

Patrick C. Guerriero

Jim Haber

Joseph Haley and Eric Tingdahl

Lisbeth J. Hall

Philip K. Hamilton and Mary C. Hamilton

Michael Hammerschmidt

John D. Hancock and John F. Wood

Carolyn E. Hannauer

Susan R. Hansberry and Mitchell L. Hansberry

Dean T. Hara

Ruth E. Harcovitz

Robert S. Hark and Richard A. Berry

Stephen M. Harney

Ross Harpestad

Stephen C. Harrison and Tomas Kirchhausen

Carol Hartman

Mark A. Hayford

Alan S. Healy and Christina S. Healy

Susan Hegel

Deborah Heller, PhD and Ann Sanders

Paul Hempel

Neil F. Henderson

Robert J. Henry, MD

Mark A. Herdeg and Zane Kuchera

Gerard W. Herlihy

Joanne Herman and Terry Fallon

John E. Hershey and Anna S. Hershey

Marcie Hershman

Christopher P. Hesen and John W. Bethard

Marjorie R. Hess and Rudolph J. Talaber

Jeffrey J. Hickey and Christian F. Brocato

Luke R. Hill and Mary E. Driscoll

Charlie Hindmarsh

An G. Hinds

Kenneth F. Hirschkind

Sheilah M. Hoelscher and Melissa A. Stockbridge

Jane and Bradley Honoroff

Peter E. Hornstra

Roland P. Houde and Mary G. Houde

Robert E. Housman and Sue T. Housman

Derek A. Howe and Brian S. Galloway

Laura J. Howick and Dale J. Szczeblowski

Yanling Huo

Ellen Hurvitz and Barry Strasnick

Jan Hurwitz and Joan Seidel

Richard L. Iandoli, Esq.

Justin T. Isaac

Raphael Jaimes-Branger and Eliot T. Wright

Katherine A. Jantzen and Ronald Michaels

Herman C. Janzen and Gary A. Godin

Maria Jasin

Mary C. Jigarjian and George Jigarjian

Maurice P. Joffe

Wendy E. John

Deborah A. Johnson

Ian W. Johnson

Patricia A. Johnson

Peggy L. Johnson, MD and Koni Ross-Johnson

Robb W. Johnson and Richard J. Gosselin

Willard M. Johnson

Jennifer L. Jones

Peter F. Jones and Wayne G. Gaffield

George H. Joseph

Lionel S. Joseph

Marvin H. Kabakoff

James C. Kaddaras, Jr.

Minai Kam and Amy Murrett

Gary B. Kaplan

Leslie M. Kaplan

Elizabeth Kass, MD

Rob Kassel

Todd A. Katzman and Marc Lacasse

Susan Kaufman

Barry A. Kean

Terence M. Keane, PhD and Douglas H. Hughes, MD

James M. Keating

Susan Kelley and Peter Kadzis

John E. Keon and Claire T. Keon

Kathy L. Kerby and Benjamin Littauer

Mary Kercz and George R. Embleton

William W. Kimball

Jonathan R. King and James Stott

Susan F. Klein

Leslie C. Knapp

David E. Knudsen

Keith D. Kohl

Peter Konrad and Shaun Watson

Andrew W. Koppel

John Koss and Charlie Compton

G.P. Paul Kowal

Mary W. Kowit and Joel D. Kowit

Jeffrey A. Kramer

Michael A. Kramer, DDS, DMSc

Stanley Kramer

Ellen Kranzer

Linda J. Kraus and Thomas D. Kraus

Thomas E. Krueger

Ben Kudler

Karen F. Kupferberg

Ralph A. Kusinitz

John S. Kyper

Robyn Laing

Gerry O. Lake

David Lampariello, OD and James Summers, Jr.

Stewart J. Landers, Esq. and John Boyce

Peter A. Lans

Peter LaPlante

Gregory L. Larson and Stefanie K. Larson

Suzanne Lascoe

Lewis Lasher

Cathy J. Lavoie Griffin and Thomas W. Griffin

Janet Lawn and Maryann Chaisson

David E. Lefebvre and Amy LeFebvre

Seth L. Levenson and John Cunningham

Lorenzo Lewis, Jr., MD and Eva Schoenfeld

Mark H. Libenson, MD and Lisa M. Muto, PhD

Steven L. Lieberman

Diane K. Lincoln

John Lisker

Jonathan S. Litt, MD

Daniel and Deborah Lolik

Sue Lonoff de Cuevas

Jack Lottey and Frances Lottey

William E. Louie

Margaret A. Lourie

Daniel A. Lowen

Richard Lu

Kathleen A. Luvisi and Margaret Luvisi

Kristin K. Lynch

Malachy C. Lynch

William T. Lynch and Ingrid G. Larson

Peter Machinist and Alice R. Machinist

Lucy Mack

Robert W. Mack

Edmond R. Macri

Matthias D. Maguire

Diane L. Mahana

Susan Malspeis

Judith G. Mannheim

Melvin A. Manson

Michael Manthei and Benjamin Manthei

Elizabeth L. Marks and Paul A. Taylor

Mary and Alan Marshall

Rebecca and Carla Marshall-Waggett

Brian Martin

Lawrence A. Martin

Thomas J. Martorelli

Jonathan I. Matsui, PhD and R. Bryan Smith

Gal Mayer, MD

Kenneth H. Mayer, MD

Charles Mayo and Mary Ellen Mayo

Kimba R. McCant

Sean M. McConnell

Matthew J. McCormack and Kelly E. McCormack

Robert McDonald

Thomas E. McDonald

Kevin F. McElroy

John McGrail

Thomas McGrath

Lynda McGraw

Michael E. McHugh

Arthur P. McIntosh

Vinnette A. McKay

Andrew W. McKinley

Theresa M. McLaughlin

Joanne J. McLean

James H. McQueen

Matthew McTygue and Todd A. Rivers

Anne Meade

Jeffrey B. Meaney

Raul G. Medina and Bradley Ursillo

Robbie J. Meitler

George Mercier

Christiane E. Merrow

Myron Merrow

Daniel A. Michaud, MPA and Brice Booker

Laila J. Michaud

Neil Miller

Scott Miller and Lorraine Miller

Stephen Minicucci

Vicki E. Mistacco

Brian T. Mitchell

Thomas Mitchell

Robert F. Monaco

David L. Montanari and Sara L. Rubin

Lynda Morgenroth

James M. Morgrage

Betty I. Morningstar and Jeanette Kruger

Ruth E. Morris and Peter G. Kelly

Chad C. Mosca

Fredric A. Moscowitz and John T. Stella

Eva S. Moseley

Edmund A. Mroz and Celia B. Shapiro

Peter Muise

Robert Muller

James R. Mullin and Wendy K. Mullin

Kathleen M. Mundhenk and Charles F. Mundhenk

Jeffrey H. Munger and Robert T. Whitman

Zara and Janice Muradali

Florence M. Murphy

Kathleen M. Murphy

Joseph F. Murray

Robert Y. Murray

Margaret J. Murtagh

Carl D. Nagy-Koechlin and Beth Nagy

Margret O. Nelson and Andrew W. Nelson

Daniel S. Newton and Christopher L. Flynn

Dona L. Nicholas and Stephen Peckiconis

Patricia A. Nichols-Cordero and Andrew P. Cordero

Lindsey L. Noecker

Karen Norlin and Richard D. Norlin

Karen M. Norris

Peter A. Norton and Elizabeth H. Norton

Patricia T. Oakes

David Paul O’Brien

John T. O’Keefe and Mark D. Smith

Patrick B. O’Neal

Elizabeth E. Oppedisano

Roberta L. Orlandino and Brenda S. Gailhouse

Christopher Orlando

Susan P. Otis and Richard G. Foote

Constance L. Otradovec

John E. Paap and Mary L. Paap

Melissa Padley

Allison Page

Liz Page and Marianne Stravinskas

Lisa Paine, CNM, DrPH and Linda Daniels, PsyD

Robert H. Paisner and Elizabeth Paisner

Samuel Pang, MD and Andrew Pang

Marcia A. Parisi and Robert J. Parisi

Faith K. Parker and Glenn P. Parker

Elizabeth C. Parsons

Kunjal Patel

Robert P. Patten and Valerie A. Yarashus

Brian J. Pattullo and Raymond A. Brown

Kerry A. Payson and Mark H. Payson

Ann Pearson and K. Brook Herren

Theodore A. Peck III

Thomas D. Penque

Stephen P. Pentek

Nicholas Pepe

Ronald F. Peracchio

Roy D. Perdue

Judith E. Perlman

Brian K. Perry and Kevin Crawford

Stephen C. Perry and Oliver Radford

Anne M. Peterson and Mark A. Peterson

John J. Petrowsky and Thomas B. Vise

Rob and Elizabeth Phelps

George Phillips

Jay Philomena

Jeff D. Pike and John Kelly

Michael J. Piore and Rodney L. Yoder

John R. Pitfield, Esq. and Paul E. Lynch, MD

Tina M. Pittore

Joseph P. Poirier

Kristen E. Porter and Andrea Boyer

Jane D. Powers, MSW, LICSW and Margaret M. Hayes

Berit Pratt and Cornelia Smith

Charles Q. A. Pratt and Alexandra I. England

Brian Price, MD and Paul D. Anagnostos

Carla Procaskey and D. Anthony Flanders

Michael Prokosch and Rebecca A. Pierce

Philip E. Pryor

Judith M. Quanrud and Richard B. Quanrud

Maureen Quinn-Dupont

Maria A. Quiroga and Alvin Shiggs

Joseph D. Raccuglia, Jr.

Cara Rader

Alicia and William Ramos

Brian Ramos

Dante A. Ramos and Ryan Smith

Dennis R. Ramsier

Jeffrey T. Ranahan

Raushi and Sylvia Raushi

Robert and Wendy Reasenberg

Abram Recht and Martha Recht

Charlotte E. Reece

Mark W. Register

Sheila B. Rehrig and Brian H. Rehrig

Rachel D. Reisman

Michael L. Reney and Alexander Cruz

Ken Reyes and David M. Slatcher

Phyllis D. Ribakoff

Gena Ricciardi

Louise B. Rice and Tess Ewing

Bruce Ricker and Karolyn Ricker

Louis F. Risoli and Charles B. Fisk

Peter E. Rivard

Janet P. Robbins

John G. Robinson and Ragnhild Fredriksen

Carol A. Roby and Michele Rubin

Jose L. Romero, Jr. and William I. Allison

Valentina Rosa

Jon Z. Rosbrook

Paul and Carol Rose

Abby S. Rosenberg

Leon V. Rosenberg and Marilyn L. Rosenberg

Michael Rosenfeld and Naomi Rosenfeld

Jay K. Rosengard

Jonathan S. Rotenberg

Karen S. Rotenberg and Michael Rotenberg

Ethel R. Roumeliotis

L. Mari Rovang and Howard L. Mathison

Arlene Rubin

David J. Russo, Jr.

John P. Ryan

Michael P. Ryan

Elizabeth A. Saef and Edward C. Saef

Steve A. Safren, PhD and William F. Pirl, MD

Arnold E. Sapenter and Joseph C. Reed, PhD

James C. Sargent

Mary Kate Savini

John Scanlon

John N. Schaechter

John J. Schaeck

Stephen E. Schlesinger

Carole Schlessinger

James W. Schmidt and Jane E. MacDonald

Jon P. Schum and Ronald V. Lacro

Warren M. Schur

Anthony Schwartz and Claudia Schwartz

Susan G. Schwarz and Philip S. Schwarz

Carl M. Sciortino, Jr., MPA and Francis P. Brown

Mary L. Scudder

Lisa E. Sebell-Nevins

Glenn A. Seberg

Joan M. Seifert

Robert W. Seifert

Ellen Semonoff

Carol A. Sestito and Kathleen A. Bower

Douglas P. Shaheen and James Rodenmacher

Lyn Shamban

Brian S. Shannon and Keith Bell

Stacie M. Shapiro and Alan I. Shapiro

Sarah A. Sharpe

William S. Shaw, PhD, PE and Paul Silva

Gregory J. Shesko and Marilyn M. Shesko

Donald L. Shulman and Jill D. Shulman

Diane Sidorowicz and Lourdes Rodriguez

Christine W. Siegrist and Richard Siegrist

Andrew Sigel

Tony Sigel

James K. Sisterson and Ellen S. Kemp

Michael Skrip and James M. Brown

Luther W. Smith

Pamela A. Smith and Steven E. Thomas

Willard A. Smith and Regina M. Scanlan

Gregory Snow

Richard L. Snow

Kevin O’Laughlin and Gregg Snyder

Diane L. Sokal and Randolph Meiklejohn

Frank T. Solensky

Judith W. Solsken

Susan Sommer

Virginia L. Spaulding

Douglas Spencer

Janet Spencer

James Spriggs

Tige T. Stading and Brian Younger

Sally A. Stalker

Blaze A. Stancampiano

Daniel and Susan Stec

Charles Steenburg

Caleb Paul Stewart

Lise Striar and Myles Striar

Claire M. Sullivan

Jo M. Sullivan and Peter Boyd

Christopher Sutherland and Steve Quezada

Deb G. Taft and Terri L. Rutter

Joseph Takarewski and Craig Sato

Amy J. Tananbaum

Timothy J. Tardiff and Annalee Tardiff

Fred A. Taub and Susan C. Cohen

Fred M. Taylor

Patricia A. Tecu and William F. Tecu

Peter Tenggren and Warren Mitchell

Hal Tepfer and Stacie L. Simon

Vic Terawskyj

Teresa Shidong Hu Memorial Fund

Joseph P. Texeira and Patricia Texeira

Carol G. Thomas

Diane Thomas

Ulysses E. Thomas

John W. Titus

Mark E. Toney and Daniel J. Hartigan

Paul and Kirsten Toomey

Laurence M. Traiman

Mark A. Tries

Steven J. Tromp

Kathleen A. Tucker

Leigh J. Tucker and Stephen R. Mehrtens

Robert F. Tucker

Patricia Turner

Jonathan M. Urbach

Kenneth A. Vaidulas

Dorothy A. Van Ryzin

Joseph C. Veneto

Robin F. Verdier

Mark Vogel

Richard Voos

Ellen Wade, Esq. and Maureen Brodoff, Esq.

James C. Wadleigh

Cathy L. Walker

J. Scott Walker

Wanda Wallace

Judith H. Walsh and Robert T. Walsh

Spencer D. Warncke and Theresa A. Belmonte

Donald R. Warren

Senator Elizabeth Warren and Bruce H. Mann, PhD

Kendall P. Watts and Robert T. Derry

Linda C. Watts

Thompson Webb and Joan M. Webb

Irene M. Weigel and Lynn B. Weigel

Robert S. Weinstein and Elizabeth S. Ginsburg

Angelika Weis-Amon

Susan K. Weiss

Lynn G. Weissberg

Karen A. Welling

Mary K. Werler

P.J. Wheeler

Anne M. White

Philip White

Christine E. Whiteside

Ann M. S. Wiencek and Paul R. Wiencek

Louis Wiley

Kim Williams and Trevor Miller

William H. Williams and Sally H. M. Williams

Robert Willis

Jean and Richard Wilson

Rosemary N. Winfield

Henry N. Winslow

John F. Winterle, DMD

Steven J. Wolf

John P. Wolfarth and Kevin W. Powers

Michael T. Wong, MD

Christopher A. Wood

Rufus Woodard and Oliver Pomeroy, MD

Donald E. Woodford

Adam A. Wright and Joseph J. Noonan

R. S. Wright

Kevin P. Wulff

Donald M. Wunder and James A. Oliver

Kathy and Richard Wunderlich

Marc Wurbel and Jerome Urvoy

David Wypij and Timothy M. Baum

Joblin C. Younger, Esq.

Diana Yount

Richard J. Yurko

Albert P. Zabin and Judith L. Zabin

Leora R. Zeitlin and Stuart S. Kelter

Joseph D. Zibrak, MD

Stephen H. Zinner, MD

Michael F. Zito

Robert Zverina and Kathy A. Spiegelman

Sustainers – Tier 2

5-9 years of support

Anonymous (3)

Godwin C. Aduba and Tim Byrne

Bailey Andrews

Mary Ellen M. Andrews

Clint Attebery

Anita Baglaneas

Ashley Banfield and Emily Drahzal

Erin Bates-McNamara

Patricia Baudoin and Madge Kaplan

Davia Berlfein

John-Paul Bettencourt, DO, MPH

Mitchell Bilczewski

Andrew E. Bishop

Richard Blank and Lauren Inker

Mara Blesoff

Shelley R. Bochner and Richard W. Boylan

Marcus C. Bogue III and Nancy A. Bogue

Kyle D. Bowman and Patrick Dykes

Graham T. Brown

Amy Burke

Michael C. Burns

Kathleen Cammarota

Sean Camp

Alexander G. Carlock

Francisco Castro and Richard D. McCarthy

Stewart and Patricia Chapin

Gary A. Christensen

Jacqueline Chu

Terry Clewley

Bren M. Cole

Gillian Comito

Brianna Connolly

Patricia A. Connolly, MD

Richard T. Conway

Matthew R. Cotty

Rebecca Davis-Carden and Chloe Davis-Carden

Edward P. Divino

Katelyn Dolan, PT, DPT

Alma-Lynn Dupont

Donna and Gerry Dyer

Michael Erb

Gary Fallas

Janice Forsstrom

Andrew Foster

Thomas E. Francione

Alexander Freedman

Janet and Andrew Gainer-Dewar

Isabella M. Gambill

Elsa Gelin

David A. Georgantas

Marc Giles and Andrea Maher

Sharon Glasser

Alexa A. Gomez

Alfredo Gomez

Cynthia M. Goncalves and Shane A. Depina

Eric C. Green

Darrel Griffin

Anthony Grillo

Megan Hall and Honor MacNaughton

Mitchell Hamilton

Taylor S. Harris

Timothy B. Harwood

Kristie Helms

John S. Hoag

Mary Ellen and Paul Hoberg

Andy Huang

Christopher Iaquinto and Sara Mattern

Eric R. Jaukkuri

Lorraine Jones and Elizabeth Halstead

Steven L. Jones and David Langer

Judy Kaplan

William S. Kaufman

Kenneth W. Kendrick, Jr.

Audrea Laffely and Sarah Madey

Cei Lambert

Mary Landrigan-Ossar, MD, PhD and Jacob Ossar

Nicole Langlois

Susan LaRosa

Ted T. Lee

Nadya Lefaivre

Joanne G. Lembo and Lee Williams

Brian P. Levin

Dana Lyford

Maureen A. Maimone and Carmine Maimone

Mina S. Makarious

Elizabeth and Lisa Marchetti

Stephen Martyak

Robert McBride

Craig McClain, MD, MPH and Natalie McClain

Sarah McWhirter

Michael Meidinger

Roland Merchant

Matthew Metivier

Paul O. Miller

Renee L. Miltz

Neal Minahan and Eric Archibald

Katharine Moore

Kendra E. Moore, PhD

Richard S. Morgan and Charles E. Smith

Bess Moser

Alex Myers and Lisa Tipp

The Naida S. Wharton Foundation

Gregory B. Nash

John Nay

Mustafa Noor, MD, FACP and Gordon Nebeker

Michael Oliveri

Richard Osgood

Jon Pate

Pelz Charitable Lead Trust

Marcia Pence and F. Howard Pence, Jr.

Wendy Perez

Corbin Petro and Jessica Gelman

Elizabeth Pilgrim

Trevor Pollack

David J. Poorvu and Nancy Poorvu

Adrianna Preston-Sicari and Amanda Preston-Sicari

Ernest J. Pusateri

Jeanette Quinlan

Helen Raizen and Kathy MacDonald

Rebecca P. Rehm

Lucille Rexroad

Amy Ross and Dana M. Ross

Lynda Rubin

YK Lee Rubin

Jonathan M. Ruiz

Phil Saines

Vardit Samuels and Richard Samuels

Stephanie Sandler

Fillip Saraiva

Paul Sherman and Susan Gill

Douglas B. Skillins and Karen A. Skillins

Leslie Smith

Naomi Sobel and Becky Silverstein

Daniel Solworth

Erina and Julia Spiegelman

Joseph Sullivan III and Jay Qu

Jeffrey Sulloway

Dominick Tribone

Diane M. Tucker

Charles Turgeon

Patricia Umile

Steven J. Vacca

John F. Wardle

John C. Welch, DNP

Todd Williams

Scott R. Wilson

Sara Winthrop

James Witek and Mark D. Pettegrow

Lauren E. Wojtkun

George D. Wright IV

Brady Wyrtzen

John Yazbek

Katelyn Yorra

Carolyn R. Young

Yijie Zhang, PhD

Jose R. Zorola

Supporters – Tier 1

3-4 years of support

Anonymous (3)

Casey Accardi

Matthew Angelosanto

Steven Auerbach and Mark Scofield

Jiray G. Avedisian

Ayla Axeloons

Nicholas Beach

Alyssa Beauchamp

Jimmy Biblarz

Heidi Boucher

Jean-Phillip Brignol

Carly Broadwell

William B. Brockman and Lucy E. Hadden

Jack Bruno

Soltan A. Bryce

Dr. K. Mahala Burn

Carson Burrington

Jessica T. Caponigro

Richard B. Carey

Kevin Cassidy and Lindsay Hurley

Mary P. Chatfield

Chris Chrisanthopulos

Bruce Clark

Tim Coakley and Angela Menard

T. Coletti

Erina Colombo

Michael Condon

Stephanie Connell

Ross Cooper

Roger Cyr and William Gasdaska

David J. Davis and Tracy Thompson

Nicholas Dials and Dustin Henderson

Claire Douglas

Nicki and Elizabeth Eastburn

Chad A. Elgeziry

Jessica Fairbanks

Theresa H. Ferran and Arianna Mitropoulos

Andrew Ferris

Judy G. Gale

Phillip Giacomoni

Louesa M. Gillespie

Kevin Govoni

Warren Green

Aaron Halleck

Matthew Hamilton

Jan Hanson

Katherine Heckman

Christina Heinrich

Clinton A. Heitman

Helen C. and Michael C. Horn

Ryan C. Jarvis

Cameron Judkins and Joshua C. Judkins, PhD

Cornelia A. Kammerer

Emily Kang

Mitchell Katz

Jake Kenney

Christine Koh

William G. LaBonte and Ruthie LaBonte

Matthew D. LaBrie

Luke Lennon

Richard Lerner

Brandy Lilly

Alisa Lincoln, MPH, PhD

Ryan MacLean

Shelby Magliari

Sofia Mankin

Hanna Mar

Will Martin

Matt Mattozzi

Zachary D. McCabe

Stephen D. McCreary and Sandra McCreary

Matthew McGuirk

Malinda J. McPherson

Jaelyn Montes

George J. Mullen

Ken Nimblett

Patricia Noone

Christine Ott

Heather Ouellette

Pierre J. Peloquin and Michele C. Peloquin

Natercia Pereira

Jennifer and Catherine Petter

Monika Pichler

Brian Powrie and Adam Krueger

Jeffrey Race

Emmett Reuder

Donald J. Richgels and Mary Richgels

Joey Riddle

Caitlin Riley

Alessandra R. Robinson

Daniel Rodas

Shawon Rodger

Dalton Rodriguez

Richard Rubinstein

Earle and Pamela Rugg

Brian Sandstrom

Tyler Sanslow, DMD

Dorothy A. Savarese

William J. Sawyer and Pamela P. Sawyer

George Scialabba

Rachel Sebellshavit

Julian Serrao

Jeremy Shaffer

Michael A. Spataro

Michael Sullivan

Jona Tanguay

Matthew Tenore

Brianda Thompson

Daniel Treacy

Elizabeth Tripp

Patrick Turner

Elizabeth Van Itallie

Thomas Velazquez

Alyssia Venna

Travis Waldrop and Shawn Goodwin

Lindsay Waller

Eric York Wallischeck

Brian C. Ware

Richard Waterhouse

Parker Wellington III

In Kind Support

Fenway Health is grateful to the following individuals and companies who came forward with in-kind support, and in doing so have helped to advance Fenway’s mission.

America’s Test Kitchen

Anchorage by the Sea

Anchor’d Inc

B/SPOKE Studios

Ball Square Fine Wines

Barbershop Deluxe

Bayside Resort

Bear Moose Brewing

Bikes Not Bombs

Blu Day Spa

Book of the Month

Brattle Book Shop

Bright Lights Designs

Brix Wine Shop

Brookline Booksmith

Brown and Coconut

Caffe Nero

Cairncrest Farms

California Cryobank, Inc.

Charles River Canoe and Kayak & Paddle Boston

Club Cafe

Community Rowing, Inc.

Coolidge Yoga

Corepower Yoga – Comm Ave

Daily Burn

Down Under Yoga

Fischel

Fox City Beard

Garbage to Garden

Glo

Gunstock Mountain Resort

Haley

Hinds

Hotel Commonwealth

House of Tafari Wraps

Huntington Theatre Company

Hy-Line Cruises

Intriguing Hair

Jack Black

JP Centre Yoga

Kerr

Linda Wellness Warrior

M. Flynn Jewelry

Manduka

McInerney

Meal Mantra

Myers + Chang

New England Plastic Surgical Associates

OoOtie Boston Bow Ties

Peabody Essex Museum

Peet’s Coffee and Tea

Pilgrim Monument and Provincetown Museum

Poised Clothing

Polkadog Bakery

Provincetown Art Association and Museum

Pyara Spa & Salon

Red Dog Pet Resort & Spa Boston

Red Sox Foundation

Remnant Brewing

Saldare Body Therapy & Wellness Studio

Springfield Museums

Surfside Hotel & Suites

Swanson-Welton

The Common Man Family of Restaurants

The Elsewhere Salon

The Inn on Carleton

The Red Inn

Theatre Direct Int’l/Broadway.com

Timberland LLC

Total Image Consultants

Total Wine & More

Trill Fit

We Grow Microgreens, LLC

Legacy Society

Gift planning is the marriage of philanthropy and sound financial planning. By making a bequest to Fenway Health through a will or trust, naming Fenway as a beneficiary of a life insurance policy or retirement plan, or creating a life income plan to support Fenway, these donors are forging a lasting legacy that benefits the people they most care for, and those who depend on Fenway.

Anonymous (10)

Robin A. Atlas, MD and Talia N. Herman, MD

Joan Ayers and Diane Patalano

Jeffrey C. Banks

Raymond L. Barnes

Marcia Bernd

Michael and Jennifer Borislow

Stephen Boswell and John Neale

Graham T. Brown

William G. Burton

Joseph R. Caputo

Michael A. Castellana and Robert Rothery

Stewart B. Clifford, Jr.

KC Cowan*

Ryan W. Cunningham, Esq.

John M. DeCiccio

Nannette L. Dumas

Stephen M. Earheart

John R. Ehrenfeld

Stephen J. Engler and John S. F. Lopes

Kyle Y. Faget, Esq.

Philip Finch

Steven F. Fossella

Brian K. Gerhardson

Adam Graves

Dean T. Hara

Timothy B. Harwood

Deborah Heller, PhD and Ann Sanders

Paul Hempel

Joanne Herman

Charlie R. Hindmarsh

Kenneth F. Hirschkind

Ralph Hodgdon and Paul McMahon

Howard Hoffman

Justin T. Isaac

Robb W. Johnson and Richard J. Gosselin

John D. Kane*

Terence M. Keane and Douglas H. Hughes

Keith D. Kohl

G.P. Paul Kowal

Michael A. Kramer, DDS, DMSc

David Lampariello, OD

Ken A. Levine

Rhonda Linde, PhD

Edmond R. Macri

Theodore V. Marsters

Patrick J. McNamara

Thomas J. McNichol

Louis M. Meucci

Paul O. Miller

Kendra E. Moore, PhD

Jeffrey H. Munger and Robert T. Whitman

Joseph J. Nicholson

Matthew B. O’Brien

Rev. Fr. Alex Oneto

Dale Orlando*

Liz Page

Lisa Paine, CNM, DrPH and Linda Daniels, PsyD

Stephen P. Pentek

James P. Phillips

Michael E. Profenno

Brian Ramos

Rick Redmond

Ruth and Robert Remis

Louise Rice

Louis F. Risoli and Charles B. Fisk

Carol A. Roby and Michele Rubin

Jose L. Romero, Jr. and William I. Allison

Ronald Jack Brunner Estate

Carol Tye Rose

Allison Salke

Arnold E. Sapenter and Dr. Joseph C. Reed PhD

Sarah Schochet and Darrah March

James R. Seligman, DMD

Douglas Spencer

Scott E. Squillace, Esq.

Charles E. Steinman and John C. Marksbury

Caleb Paul Stewart

David Todisco, MSW, LICSW

Diane Tucker

Bradford W. Voigt

Liz Whittemore

Edward L. Wierman

David R. Yalen

Joblin C. Younger, Esq.

*Deceased

Tribute and Memorial Gifts

Tribute and memorial gifts provide a unique way for people to acknowledge loved ones and others who have had an impact on their lives. Whether honoring individuals who believe strongly in our mission, or memorializing those who have passed away, these gifts help Fenway provide access to quality care for all those who need it. Celebrated through gifts in their honor or memory, the exceptional people listed here have made a lasting impact on the lives they have touched.

Gifts were made in honor of:

The AI Team

Peter Ansin

Abraham Bayer

Emily Beaulieu

Dr. Jim Bonanno

Bob Bott

Ron Breault

Patricia and Michael Capistron

Dr. Alex Gonzalez

Warren Green

John Kenneth Harper

Charlie Hindmarsh

Cheryl Katon

Dr. Steven Keenholtz

Jay Keon

TT King

Eva Lundsager

Dr. Kenneth Mayer

Mary Bety McInerney and Susan Barclay

Lee D. Morrissette

Kerry Patterson

Martha and Joel Pierce

Dylan Rice

Michael Roffi

Ralph Rosenberg

Dana Sbeck and Jim Orshaw

Raymond Sheelan

Ace Ziobro

Gifts were made in memory of:

James Ackerman

Leelah Alcorn

Peter Ansin

Donald F. Bennington Jr.

Tom Bowers

Dr. Judy Bradford

Donny Bresnahan

David Brooks

Francis Cappiello

Barbara Cocca

Eliot Cohen

Rick Cohen

Paul Richard DiNardi, Jr.

Richard Doyle

Ian Edwards

Jerry Fensterman

Michael Gaskins

Thomas F. Gibbons

John P. Hang

Liz Hastie

Shirley Jayne Henjum Meucci

Richard Houston and Frank Cappiello

Lois Johnson

Rudy Kikel

Holly Ladd

Rick Larkin

Dr. Mark Lerner

Rush Limbaugh

Gene Lipsky

Joseph M. Lupo

John Mahler

Jason Maimone

Joshua Malin

Fred Mandel

Kevin Michael Martin

Ed Martin

Bill Morong

Richard Dorsey Muller

Graham George Newsome

John W. Passe

Dr. Steven Rose

Andre Rossi

James Ryan

David Scondras

Michael C. Smith

Michael Stewart

Karen Thomas

James M. Tries

Billy Warner

Louis Weingarden

Doreen Wilde

Alyce Winfisky

Donge Zedo

Young Leaders Council

The Young Leaders Council is an initiative of Fenway Health that aims to empower emerging LGBTQIA+ leaders and allies to shape their community’s future. Paving the way for generations to come, YLC members exhibit the best of the young LGBT community. Members are individuals in their 20s and 30s who’ve made an annual gift of $300 or more between July 1, 2020 and June 30, 2021.

Casey Accardi*

Hammad Ahmed

Adam S. Albano

Ceceilia Allwein

Bailey Andrews

Clint Attebery

Jiray G. Avedisian*

Ashley Banfield and Emily Drahzal

Kaytie Beasley

Alyssa Beauchamp*

Emily Beinecke

Karina Bercan

Mitchell Bilczewski

Andrew E. Bishop

Mara Blesoff

Nicholas Bradley

Dominique Brewer

Megan Bruce

Timothy Burdsall*

Dr. K. Mahala Burn

Lindsay Centofonti

Dan Chadwick

Alexandre Chaumette

Dr. Laura Chivers

Russell Cloon III*

Bren Cole

Erina Colombo

Gillian Comito, Co-Chair*

Brianna Connolly

Kat Delos Reyes*

Katelyn Dolan, PT, DPT*

Lauren Doty and Casey Brown

Rosemary Dowling*

Bridget Dunn

Alma-Lynn Dupont

Steven P. Dyer

Chris Erchull and Cade Jerome

Kimberly T. Erwin

Theresa H. Ferran* and Arianna Mitropoulos

Paul Flagg

Thomas E. Francione

Isabella M. Gambill*

David A. Georgantas

Tracy Germann

Colin Gibbons

Charlotte Glasser and Genie Gore

Carolyn Grillo and Erin Deadmon

Cyrus Hamer*

Taylor S. Harris

Katherine Heckman

John S. Hoag

Andy Huang

Jack Bruno

Maxine Jackson

Jillian M. Jennett*

Ian W. Johnson

Cameron Judkins and Joshua C. Judkins, PhD

Jamie Kmak*

Ted T. Lee

Austin Lessin

Jillian Levine and Sherry Cheuk

Casey A. Liston*

Jonathan S. Litt, MD

Dana Lyford

Ryan MacLean

Sofia Mankin*

Will Martin

Zachary D. McCabe

*SteerCo Members

Malinda J. McPherson*

Michael Meidinger

Brian T. Mitchell

Arianna Mitropoulos

Jaelyn Montes

Alexander Nally

Kevin Peterson

Tina M. Pittore

Amanda and Adrianna Preston-Sicari

Emmett Reuder*

Gena Ricciardi

Lewis Rieley and Bryan Barbieri

Fiona Roberts

Alessandra R. Robinson, Co-Chair*

Shawon Rodger

Tyler Sanslow, DMD

Julian Serrao*

Naomi Sobel and Becky Silverstein

Julia Spiegelman

Jeffrey Sulloway

Jona Tanguay

R. Mitchell Thomas

Dominick Tribone

Elizabeth Van Itallie

Alyssia Venna

Ying Wang, Esq.*

Adam C. Weiss

Scott R. Wilson

Lauren E. Wojtkun

Jared M. Worful

George D. Wright IV

Brady Wyrtzen*

John Yazbek

TFI Volunteers

Fenway Health HIV Patient Community Advisory Board

Rick Boyd

Paul Buzzell

Glenn Campbell, Co-Chair

Anthony Carpinelli

John Donnelly, Co-Chair

Doug Douglas

Jayson Duley

Timothy Jordan

Zamir Mavo

Maria Muse

Bruce Reisman

Max Sigal

The Fenway Institute Community Advisory Board – Adult

Nathaniel Alemayehu

Coco Alinsug

Khaoula Ben Haj Frej

Jay Bourgeois

Reese Caldwell

Lucas Carstensen

Gary Daffin

Quinn Fitzpatrick

Kirsten Freni, Chair

James Grant

Sunil Gulab

Shane Hebel

John Isaac

Autumn Jarrett

Harrison Knowlton

Rick Li

Fred Mazyck

Conor Nistler

Elizabeth Quinn

Jimit Raghav

Zach Schwartz, Chair

Kim Wilson, Chair

Antonio Xu Liu

Joelle Zaslow

Ben Zola

The Fenway Institute Community Advisory Board – Youth

Nathaniel Alemayehu

Asa Badalucco

Daniel Kwon

Evelyn Hartenstein

Jennifer Judge

Huy Nguyen

Alex Pan

Anisha Patel

Maddie Scavotto

Regina Tham

Sara Wexler

The Fenway Institute Institutional Biosafety Committee

Alicia Anderson, MBA, FACHE, BB

Bill Anderson, PhD

Amy Ben-Arieh, JD, MPH

Jeffrey Bonnaud, MHS, PA-C

Jennifer Campbell, PhD, Chair

Mark Cayabyab, PhD

Gerry Colvin, DO

Bruce J. Dezube, MD

Abby Hornstein, MD

Chee-Seng Lee, PhD

The Fenway Institute Institutional Review Board

Cole Ayasse, PhD

Amy Ben-Arieh, JD, MPH

Elizabeth Boskey

Sarabeth Broder-Fingert, MD, MPH

Kevin Cates, MD

Kristen Connal

Bryan Cook, PharmD

Mark Dávila-Witkowski

Sandy Falk, MD

Jamie Flaherty, JD

R Feynman

Eli Godwin

Anna Gurevich, JD

Daniel Jones, MSN, RN

Megan Kwock

Dana Longobardi

Yvette Marts, MSc, CIP

Will McIntire

Jennifer Mitty, MD, Chair

Majagamy Ramos

Jason Santos, MPH

Reiner See, MD

Carl Streed, Jr, MD

BOOMERANGS

Shop Thrift. Fight AIDS.

Boomerangs was started as part of a long-term strategy to diversify revenue streams in the face of declining state and federal funding. As public funding for HIV support, prevention and education programs continues to dwindle, this entrepreneurial approach allows Fenway Health and AIDS Action to continue providing services—the need for which increases each year.

During fiscal year 2021, Boomerangs faced serious challenges due to COVID-19. Along with many other retailers, we were forced to operate at reduced capacity for several months following our temporary closure earlier in 2020. We reconfigured our stores and donation system to help keep our staff and shoppers safe and healthy and expanded our online shopping options.

Despite those challenges, Boomerangs continued in our mission to raise funds and awareness for HIV services and programs. Thank you to everyone who stood by us and who continues to shop at our three brick and mortar stores and online. Your support means the world to us.

Our Stores Feature

Furniture

Artwork

Books

Clothing

Jewelry

Our Special Edition store in the South End is highly curated to realize the full potential of high-end donations.

Online Shopping

In addition to our brick and mortar stores, Boomerangs has a variety of online storefronts, including Amazon, Etsy, Ebay, and Poshmark. Learn more and check out our online sales here.

In fiscal year 2021, Boomerangs was named

Best Place to Shop Antiques, Vintage, and Thrifted Finds in Boston by AutionNinja

Thrifting Helps the Environment

Synthetic clothing may take hundreds of years to decompose in a landfill. If the average life of clothing was extended by just three months, it would reduce by five to ten percent their carbon and water footprints, as well as waste generation. The recycling of two million tons of clothing per year equates to taking one million cars from U.S. streets. Read more about the benefits of textile thrifting and recycling here.

You can shop Boomerangs from three Boston locations.

Jamaica Plain

716 Centre Street
Jamaica Plain, MA 02130

Central Square

563 Massachusetts Avenue
Cambridge, MA 02139

South End

1407 Washington Street
Boston, MA 02118

Connect with us Online

Website

Facebook

Twitter

Instagram

Shopify

Etsy

Ebay

Amazon

Financials

Our financial future is strong. We continue to operate responsibly and efficiently as is demonstrated in this report. This strength will enable us to build on our successes, anticipate the needs of our community, and better reach underserved groups, no matter how great the obstacles, nor how significant the challenges.

Click below to download the combining statements of financial position for FY21 and FY20.

Year in Review

2020-2021

Welcome

Welcome

STRATEGIC PLAN & RACIAL EQUITY ACTION PLAN

STRATEGIC PLAN & RACIAL EQUITY ACTION PLAN

Fenway @ 50

Fenway @ 50

Response to COVID-19

Response to COVID-19

Healthcare

Healthcare

Education

Education

Research

Research

Public Health

Public Health

Advocacy

Advocacy

Events

Events

Supporters

Supporters

Boomerangs

Boomerangs

Your Care, Your Community

Message from our CEO

Medical

Behavioral Health

Dental

Vision

174

20

16,431

59,000

Fenway researchers and educators are frequently published in:

Our faculty present at national and international meetings and conferences including:

313,359

393,360

463

832

35

18 Rides

45 Riders

$111,292 Raised

STRATEGIC PLAN &
RACIAL EQUITY ACTION PLAN

STRATEGIC PLAN &
RACIAL EQUITY ACTION PLAN